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Abstract
Every year in the United States, more than 500,000 bone graft surgeries are
required. In most cases, bone will regenerate after fracture with minimal com-
plications; however, when there is a critical-sized defect or fracture healing is
impaired, bone grafts must be used in order to regain proper bone function.
Additionally, bone diseases such as osteoporosis, infection, skeletal defects, and
bone cancer may also cause a need for bone grafts. Bone tissue engineering
offers a possible solution to the supply problem plaguing current bone graft
therapies by providing a near limitless supply of bone for reimplantation. Fur-
thermore, because tissue engineered bone would be made using the patient’s
own cells, risk of immune rejection would be eliminated. Unfortunately, cur-
rent bone culture techniques suffer from one or more of the following: 1)
inadequate cell adhesion to the underlying scaffold; 2) poor or lack of proper
quality control and repeatability; or 3) requiring destructive methods to judge
construct quality.
During the last decade, the number and effectiveness of in vitro cancer
models has increased dramatically. Utilizing a variety of techniques for 3D
culture, researchers have created models that more closely resemble and predict
in vivo tumor drug responses; however, the same hindrances faced in bone
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tissue engineering occur with some in vitro cancer models. In particular, these
in vitro models consistently exhibit poor cell proliferation and distribution,
which severely limits their predictive capabilities. The number one hurdle that
must be overcome is the poor adhesion that cancer cells have to non hydrogel
scaffolds, which severely limits the development of tumor models that contain
fully developed tissue.
These aforementioned issues highlight three major questions that will be
investigated in this manuscript: 1) How can we improve both mesenchymal
stem cell and cancer cell adherence to the scaffolds? 2) In terms of flow-induced
stresses, what is the viability of 3D printing for manufacturing repeatable scaf-
fold architectures? 3) Do the shear stresses within a bone tissue engineered
construct change over the culture period? These questions will be answered
using a combination of both biomimetic scaffold functionalization and com-
putational fluid dynamic simulations. For the former, a physical entrapment
technique which introduces free amine groups to the surface of the scaffolds
was developed, allowing for the subsequent attachment of RGD and n-cadherin
to aid in mesenchymal stem cell and tumor cell attachment, respectively. For
the latter, constructs were imaged using micro-computed tomography, recon-
structed, and imported into the computational fluid dynamic program FLU-
ENT (ANSYS, Inc), allowing for the evaluation of the flow profiles and shear
stress distributions therein. The following chapters of this manuscript will
focus on each of this questions in succession, outlining the motivations and
methods used to tackle each problem, and the results of our findings.
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Chapter 1
Background & Significance
Tissue engineering is a developing field that links biologics with engineering
to promote tissue regeneration. Key components for successful tissue engi-
neering are: an appropriate cell or stem cell source typically derived from the
patient via a cell biopsy; a scaffold that is biocompatible and bioabsorbable;
and mechanical or chemical stimuli that differentiate the cells on the construct
into the accurate cell lineage. When implanted in a patient, the tissue con-
struct is expected to influence extracellular matrix organization and construct
degradation, limit any immune reactions, all while the native tissue remod-
els and regenerates. Tissue engineering has become a very popular method
when combined with bioreactors for treating disorders of the musculoskeletal
system.
Current Strategies
Currently there are four main types of bone grafts: autografts, allografts,
xenografts, and bone cement. Autografts, where healthy tissue is taken from
1
the patients own body, are overall the best type of bone grafts, due to the fact
immune rejection is not a serious factor. In this type of procedure, healthy
tissue is taken from another site on the patients body and is then transplanted
to the desired area. However, these grafts suffer from a limited supply and
also donor site morbidity, pain in the harvesting site. In addition, these grafts
may fail due to many cells not surviving the transplantation process[17, 19].
Allografts, tissue taken from a donor of the same species, are another fre-
quently used bone replacement. They have become more common in the past
decade through the introduction of immunosuppressant drugs that help ease
the immune response from foreign tissue entering the body. Even still, they
may cause immune rejection and have limited osteoinductive abilities when
compared to autologous grafts [17].
Another graft source are xenografts, which are grafts taken from animals.
The common animals used for transplants are pigs, sheep, and goats. Unfor-
tunately they carry with them a high rate of infection and host rejection. Due
to this, xenogeneic grafts are not highly desired [19].
Synthetic Alternatives
Because natural tissue sources are difficult to obtain, many people choose to
get mechanical replacements. Table 1.1, shown below, gives an overview on
the differences between bone grafts and common bone graft substitutes. One
of the common grafts shown in the table, hydroxyapatite, is a synthetic bone
substitute that has been frequently used. It is a brittle material that slowly
undergoes bone resorption. Due to this, it is more often than not combined
with other materials to increase the speed of resorption. Another common
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Osteoconductive Scaffolds
Type Graft Osteoconduction Osteoinduction Osteogenesis Advantages
Bone Autograft +++ ++ ++ Gold Standard
Allograft +++ + 0 Availabile in
many forms
Biomaterials DBM + ++ 0 Supplies os-
teoinductive
BMPs, bone
graft extender
Collagen ++ 0 0 Good as delivery
system
Ceramics TCP,
hydroxya-
patite
+ 0 0 Biocompatible
CPC + 0 0 Some initial
structural sup-
port
Composite β-TCP/
BMA
cement
composite
+++ ++ ++ Ample supply
BMP/ syn-
thetic com-
posite
- +++ - Potentially lim-
itless supply
Table 1.1: Comparison of common scaffolds. Score: 0 (none) to +++ (ex-
cellent). A (-) indicates information that is either unknown or not provided.
DBM: demineralized bone matrix, TCP: tricalcium phosphate, CPC: calcium
phosphate cement, BMA: bone marrow aspirate, BMP: bone morphogenetic
protein. Table is adapted from the following publication [19].
material is ceramics. They are usually made from tricalcium phosphate and
have been shown to have osteogenic capabilities when they are attached to
healthy bone [31, 47]. Compared to hydroxyapatite, they have faster bone
resorption, but must also be surgically removed as the new bone grows [19].
When the whole bone is not damaged, bone cements are used. Polymethyl
methacrylate, PMMA, is a popular bone cement that works by acting as an
anchor, connecting bone to bone or bone to joint, and absorbing force in the
same fashion natural bone would. The use of bone cement is very popular due
to its widespread availability and effectiveness. The negatives of bone cement
are that it is non-biodegradable and permanent. Also PMMA bone cement
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works by exothermic free-radical polymerization. The heat it gives off during
this reaction is harmful to the neighboring tissue at the implantation site and
local cells and tissue are often damaged. Furthermore it has been shown to
bind poorly to bone surfaces [34].
1.1 Bone Tissue Engineering
Every year in the United States, there are more than 500,000 bone graft surg-
eries, with the most common needed for regenerating bone in fractural healing
[17, 19]. In most cases, bone will regenerate after fracture with minimal com-
plications; however, when there is a critical-sized defect or fracture healing
is impaired, bone grafts must be used to regain proper bone function. Fur-
thermore, bone diseases such as osteoporosis, infection, skeletal defects, and
bone cancer may also cause a need for bone grafts. Also of great importance,
are the bone problems facing astronauts during space exploration. Due to
the biology of bone, astronauts lose bone mass while they are in zero grav-
ity. This is caused by a decrease in movement and mechanical force, and in
some cases correlated to bone mineral density loss of up to 40% [73]. Given
these problems, it is ideal that we look for new bone healing methods or bone
replacements.
Bone tissue engineering is a possible solution to the problems plaguing the
current bone graft therapies. Because tissue engineered bone would be made
of the patient’s own cells, immune rejection would be eliminated as well as low
availability. For this to work, four components are needed for tissue growth:
cells that can be differentiated into bone cells, osteoconductive scaffolds for
acting as a matrix while the tissue grows, growth factors and other chemical
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stimulation, and mechanical stimulation to encourage osteogenic differentia-
tion. Mechanical stimulation is implemented through the use of bioreactors.
1.1.1 Bone Biology
Bone is a specialized connective tissue mainly used as support and structure
for the vertebrate body. Its mechanical role is to not only protect the vulner-
able tissues of the body, but to also serve as an anchor for the muscles in the
body, so they gain leverage for movement [10]. Furthermore, the bones are
used by the body to maintain a steady concentration of phosphate and calcium
ions that will be used in various homeostatic processes [23]. Bone is made up
of two different subcomponents: cortical and spongy bone. Cortical bone, also
called compact bone, is more dense than its counterpart with a porosity of
5-30% [64]. It is made of tightly packed collagen fibrils, which together form
the lamellae. These collagen fibrils are what give compact bone its strength.
By weight, compact bone contains approximately 30% matrix and 70% salt
deposit. The organic matrix consists of over 90% collagen fibrils and the rest
is ground substance, which is formed from the non-fibrous portions of extracel-
lular matrix. Ground substance, for the most part, does not contain collagen,
but it is made up of glycosaminoglycans, glycoproteins, and proteoglycans[10].
Due to the orientation of the collagen fibers, along the direction of the force
acting on the bones, the bone has a very high tensile strength compared to the
other tissues in the body. The bone salts contained in compact bone are pri-
marily calcium and phosphates. During calcification these two molecules form
a crystalline salt known as hydroxyapatite. Spongy bone, or cancellous bone,
is more loosely packed and has an average porosity of 30-90% [64]. Another
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Figure 1.1: Schematic of long bone showing its anatomy and the orientation
of compact and spongy bone. Figure used with permission from the following
publication [10].
major difference between cortical and spongy bone is their function. Compact
bone, being more rigid, provides the structural strength, while the spongy
bone provides the components for metabolic maintenance.
The shape of long bone (shown in Figure 1.1) is such that it can with-
stand the greatest amount of force. The inner section, diaphysis, contains a
higher amount of compact bone meaning that it is made of tightly packed
collagen fibrils. The epiphysis, ends of the bone, is wider than the diaphysis
and contains a higher amount of spongy bone [10].
1.1.2 Bone Calcification and Renewal
Knowing that we are growing bone, it is important to gain an understanding
on the mechanism for bone calcification. When cells are being cultured for
use in bone tissue engineering, the marker for differentiation into bone cells
is calcification. The first step consists of both collagen monomers and ground
substance being secreted by osteoblasts [31]. These collagen monomers form
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collagen fibers that, in this early state, are called osteoids. Osteoids are simi-
lar to cartilage however the rate at which calcium precipitates in it is signifi-
cantly higher [23]. During the formation of osteoid, many osteoblasts become
entrapped, and are from then on known as osteoclasts. Over the next few
months, calcium salts form on the collagen fibers of the osteoid, and in time
they undergo substitution becoming complete hydroxyapatite crystals. The
calcium salts that are not converted into hydroxyapatite stay on the fibers as
amorphous salts that can easily be released into the extracellular fluid [23].
Another important feature of bone is how it is continually being renewed.
There are two process involved in this: deposition and absorption. Deposi-
tion is the act of osteoblasts continually calcifying bone, and absorption is
the process of osteoclasts removing bone. The process through which this
occurs is still somewhat unknown. However, researchers have found that de-
position occurs through the mineralization of bone matrix and also the growth
of mineral crystal [10]. The differences between theories come from whether
this is accomplished through the use of vesicles or specific binding by cal-
cium. Under normal conditions, vescicle mediation or calcium binding happen
at approximately the same rate so that bone is both always in a full state
and continuously being remodeled. The rate at which these processes occur
is proportional to the stress put on the bones. Therefore an athlete that is
constantly moving will have a higher rate of bone remolding than a person
who sits at a desk all day.
There are two mechanisms for bone formation: intramembranous ossifi-
cation and endochondral ossification, with most of our bones following the
latter pathway. In intramembranous, or direct, ossification, masses of mes-
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enchymal stem cells differentiate into osteoblasts through the use of vascu-
larization. These osteoblasts then form osteoids, and the osteoblasts that are
inside become osteocytes. The bones that form by this process are the clavicle,
mandible, face bones, and bones in the cranial vault [31, 10].
Bones that have a constant stress from weight or movement are formed
through endochondral ossification. These bones take an intermediate step
where the initial stem cells form chondrocytes before forming the bone ma-
trix. Chondrocytes build soft tissue that serves as a scaffold for the eventual
growth of bone matrix. The templates of chondrocytes, which have formed a
vascular tissue called a growth plate, are vascularized. Then osteoblasts dif-
ferentiate around the central area of the bone. While this is happening, the
local chondrocytes turn hypertrophic and induce further vascular penetration
[31, 10, 47]. After this, osteoblasts are recruited into the forming bone and
began calcification.
1.1.3 Bone Cell Types and Sources
Native bone contains three cell types relevant to tissue engineering: osteoblasts,
osteoclasts, and osteocytes. Another important bone cell type involved in bone
tissue engineering is the osteoprogenitor cell. For tissue engineering applica-
tions, osteoprogenitor cells mainly differentiate from mesenchymal stem cells.
These osteoprogenitor cells are the precursors for osteoblasts, osteocytes, and
the bone lining cells; whereas the osteoclasts are formed through the fusion of
mononuclear precursors, such as those from hemopoietic tissue [31].
Osteoblasts are the major cell type responsible for bone deposition, the
growing of bone. Their main function is the development of mineralized tis-
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sue, which contains several proteins, such as osteocalcin and osteopontin, and
collagenases that aid in osteoclast activation [31, 10]. Osteocalcin is a noncol-
lagenous protein, created solely by osteoblasts, that is involved in controlling
the rate of bone formation and bone mineral maturation [10]. Since it is only
secreted by osteoblasts, osteocalcin is a prime candidate for identifying if a
stem cell culture is turning osteogenic, and is commonly used as a biochemical
marker for bone formation [58, 71]. Osteopontin is a noncollagenous glycopro-
tein that is responsible for osteoclast attachment and resorption [71].
Osteocytes are formed from osteoblasts that have been entrapped in the
bone matrix, and take care of the maintenance of the bone [31]. Each osteocyte
resides in its own space in the bone matrix, named lacunae and canaliculi,
and are interconnected through channels. These channels, also known as gap
junctions, serve as the passageway through which nutrients can be exchanged
with between osteocytes, blood vessels, and other places throughout the bone
[66, 10].
Osteoclasts main function is the resorption of bone. On their membrane,
they have both a smooth surface that serves as a connective area for attaching
to the bone matrix using integrins and, as previously mentioned, the aid of
matrix proteins such as osteopontin. They also have a rough surface where
bone resorption takes place. Proteolytic enzymes and acids released from this
rough border break down the bone by breaking down the organic matrix and
bone mineral [66, 10].
Like in all tissue engineering fields, the osteoblastic cell source is a very
vital part of the equation. The ideal cells for use in vitro will have a high pro-
liferation rate, an ability to differentiate into the cells necessary for the tissue
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to operate, and also the ability to deposit organic tissue matrix. The most
popular cells that are considered for bone tissue engineering are mesenchymal
stem cells (MSCs), adipose derived stem cells, osteoblastic progenitor cells, os-
teoblasts, and osteocytes. For the most part, osteoclasts have not been utilized
since they are not required for the formation of mineralized tissue. MSCs are
the most widely used cells for bone tissue engineering. MSCs have been found
to have increased osteoblastic differentiation when exposed to fluid shear, and
also have exhibited clear osteoinductive capabilities [15, 56, 37]. Furthermore
it is widely known that MSCs have a higher proliferation rate when compared
to osteoblasts and osteocytes [37].
1.1.4 Scaffolds for Bone Tissue Engineering
As with all tissue engineering fields, scaffolds are a necessity for in vitro ap-
plications. For bone tissue engineering, the scaffold must allow the cells to
not only attach and proliferate, but must also allow for mechanical stimu-
lation, encourage bone cell migration, act as a substrate for osteoid deposi-
tion, and deliver bioactive molecules [52]. Another aspect that is desired is
biodegradability. If a tissue engineered construct is put into the body, the
scaffold must degrade over time leaving only organic material that will re-
tain natural levels of mechanical strength [7, 28, 5]. The common scaffold
types used for bone growth are natural polymers (fibrin and collagen), syn-
thetic polymers (polycarbonates, polyanhidrides, poly(ethylene oxide), poly-
fumarates, and polyphosphazene), metals and ceramics [39, 11]. Due to their
controlled biodegradability, published mechanical properties, and widespread
use in polymer and tissue engineering research, synthetic scaffolds, in par-
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Figure 1.2: Common sythentic polymeric scaffolds used for tissue engineer-
ing. (left): 3D printed. (middle): spunbonded (right): solvent-cast porogen-
leached. Images were taken using scanning electron microscopy.
ticular poly(lactic acid)(PLA), poly(glycolic acid)(PGA), and poly(lactic-co-
glycolic acid)(PLGA) are the most popular candidates [39].
Currently, there are two major types of scaffolds: injectable and prefabri-
cated [19, 30]. Injectable scaffolds are desirable due to their ability to take the
shape of highly irregular bone defect sites; however, the big problem currently
facing these scaffolds is their inability to generate controllable porous networks
that can be infiltrated by host osteoprogenitors and vascular network. The lat-
ter means that if any cells do reside in the center of the construct, they will
not be able to obtain optimal oxygen and other nutrient supplies. In addition,
very carefully designed crosslinking strategies are required to avoid the release
undesirable chemicals or heat that may harm the host neighboring host tissue.
Prefabricated scaffolds, on the other hand, have highly controllable porosity
that will allow enhanced levels of nutrient delivery throughout the construct,
and also the possibility for higher mechanical strength. Common types of
scaffolds include those made from rapid prototyping such as 3D printing, fiber
meshes (woven and nonwoven), and porous foams (salt leached or gas foamed),
each of which is shown in Figure 1.2 [12, 29, 42, 43, 30, 13, 28].
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1.1.5 Cell Culture
The culture of cells for bone tissue engineering is very similar to that for other
tissue engineering fields. It is necessary to have a culture media, commonly
alpha-minimal essential media, dubelco’s-minimal essential media, or Roswell
Park Memorial Institute medium 1640, which contains the proper nutrients
for cell growth. These media often include d-glucose, l-glutamine, HEPES
(a buffer for maintaining physiological pH), phenol red indicator (for easily
identifying pH). The differences between culture media are usually in their
concentration of glucose, growth factors, and other nutrients. Another com-
monly used and essential part of media is fetal bovine serum (FBS), newborn
calf serum (NCS), or some other similar animal blood serum. The purpose
of these is to provide the cells with the proper growth factors to facilitate
cell growth. It is important to note, however, that serums must always be
screened to insure that they will differentiate cells properly; due to the fact
protein concentrations are not consistent between batches.
When bone cells are desired, osteogenic media is used. Osteogenic media
differs from regular culture media in that it contains dexamethasone, beta-
glycerophosphate, and ascorbic acid. Dexamethasone is a glucocorticoid that
has been found to facilitate bone differentiation and mineralization in cultures
[61]. Beta-glycerophosphate and ascorbic acid roles are to provide phosphate
and increase collagen fibril production, respectively [61]. Growth factors may
also be added to aid in osteogenic differentiation. BMP-2 (bone morpho-
genetic protein), as well as BMP-7, are osteoinductive growth factors that
are commonly used to enhance mesenchymal stem cell differentiation into os-
teoblasts. BMP-2 is an important growth factor as it is involved in the TGF
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beta-signaling pathway, and aids in osteogenesis, cell growth, and differentia-
tion [50, 17]. Once the cells are ready to be used for experiment, they must
be seeded onto the scaffolds. Although the procedure may vary, static and
dynamic seeding are the two most commonly used seeding methods. Static
seeding consists of injecting cells on to scaffolds that are sitting in a culture
well plate. Dynamic seeding is where the cells suspended in media are allowed
to flow through the scaffold. In theory, dynamic seeding allows for a greater
level of cell penetration.
Mechanical forces have a strong effect on the deposition and resorption
of bone. As force is applied to the bone, a pressure change occurs which
leads to fluid flow inside the lacunae and canaliculi. This of course means
that bone cells in the body are constantly being subjected flow. Studies have
shown that cell growth is stimulated by flow induced shear in vitro [49]. Shear
stresses under 25 dynes/cm2 corresponded to an increase in cell proliferation
and osteoblastic differentiation. On the other hand, shear above 25 dynes/cm2
can cause cells to detach from the scaffold matrix [72]. Therefore, research is
needed to optimize shear stresses for inducing osteoblastic cell differentiation,
and also determine the shear pattern in various porous scaffold matrices.
1.2 Bioreactors for Bone Tissue Engineering
Before one begins to culture cells for bone tissue engineering, it is of utmost
importance to pick the proper bioreactor. in vitro bone development bene-
fits from fluid flow that provides mechanical stimulation, all while improving
oxygen and nutrient delivery throughout the scaffold and removing cell waste.
For most bioreactors in bone tissue engineering, the parameter that is impor-
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Figure 1.3: Common dynamic bioreactors used for bone tissue engineering:
(left) spinner flask, (middle) rotating wall vessel, (right) perfusion flow.
tant is the shear stress associated with this fluid flow. It has been widely
seen that mechanical stimulation can affect ECM production, cell prolifera-
tion, extracellular matrix (ECM) calcification, and osteogenic gene expression
[81, 53, 32, 44, 20, 83, 64]. In order to properly accomplish this, three different
bioreactors, shown in Figure 1.3, are commonly used: spinner flask, rotating
wall vessel, and flow perfusion [81]. The following are descriptions of common
bioreactors used for bone tissue engineering.
1.2.1 Static Culture Flask
The simplest and most widely used culturing system for tissue engineering is
the static culture flask [64, 21, 3, 81]. In static cultures, cells are seeded on
a scaffold, usually by pipetting a cell suspension on the top surface, and the
construct is placed in a flask. This flask is then filled with cell culture media
and stored in an incubator, with media changes occurring intermittently. Due
to its simplicity, static 3D cultures are often used as experimental controls
along with a static 2D culture [81, 62, 64, 65]; however, static 3D cultures
suffer from severe limitations due to the fact there is no fluid flow through
the scaffold porosity, or even around it. Therefore concentration gradients of
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nutrients develop with potentially harmful results. Additionally, the absence
of shear limits osteoblastic differentiation. Studies have shown that using
3D static culture for bone tissue engineering results in low seeding efficiency,
nonhomogeneous cell distribution, unfavorable nutrient gradients, and slow
ECM mineralization [81, 20, 83].
1.2.2 Spinner Flask
Spinner flask bioreactors consist of cell-seeded scaffolds suspended in media
in a cylindrical vessel. The goal of this setup is to create convective flow
around the scaffold, through the use of a mechanical drive or a magnetic
stir bar. The stirring motion creates localized shear around the scaffolds.
Unlike other dynamic culture systems, the flow environment at the surface
of the scaffolds can be turbulent and may contain eddies with potentially
harmful results to cells residing at the exterior surface of the scaffolds. These
bioreactors have been shown to be an improvement over static cultures for
seeding efficiency, cell proliferation, and differentiation, all of which are to be
expected, since the presence of continuous mixing allows for the mitigation
of nutrient concentration gradients [64, 69]. Unfortunately, spinner flasks are
unable to efficiently deliver any siginificant amount of nutrients throughout the
3D scaffold [20, 69]. This leads to cell death near the center of the scaffold.
Another problem is lack of exposure to shear stresses for cells that are located
in the interior porosity of the scaffold. Even the cells on the surface get
exposed to inhomogeneous shear stress distributions. Given that shear stress
is a vital part of differentiation, the aforementioned inadequacies make this
system inferior to perfusion systems, as will be demonstrated in later sections
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[83, 64, 21].
1.2.3 Rotating Wall Vessel
Rotating wall bioreactors consist of a rotating outer cylinder, a stationary
inner cylinder, and an area for the culture between them. The inner wall
is gas permeable through which oxygen is supplied to the system, while the
outer cylinder is impermeable to gases and induces the dynamic field [81].
Because of the nature of the system, there is a velocity gradient in the culture
chamber, and under certain conditions a microgravity environment may be
generated [35]. Sikavitsas et. al studied rotating wall, spinner flask, and
static flask cultures over extended culture periods to compare their ability
to promote osteoblastic differentiation of mesenchymal stem cells seeded on
poly (lactic-co-glycolic acid) scaffolds [64]. When compared to perfusion and
spinner flask types, rotating wall bioreactors offered lower overall increases
for osteogenesis, ALP activity, osteocalcin secretion, mineral deposition, and
scaffold cellularity; however, these values remain higher than static 3D cultures
[80, 82]. A great advantage of the rotating wall vessels is their ability to
generate highly controllable fluid flow environments without the generation
of eddies near the scaffold surfaces. As such, rotating wall vessels are ideal
for studies where tight control of surface stresses is required, but as with the
spinner flask, the inability to provide any significant convection to the interior
porosity limits their usefulness in bone tissue engineering studies.
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1.2.4 Perfusion Flow
Perfusion bioreactors have been shown to be the most effective systems for
bone tissue engineering, and it has been found that they deliver a wide range
of easily manipulated shear stresses to stimulate differentiation into bone cells
[81, 65, 3, 14, 62]. They usually consist of a pump, media reservoirs, scaf-
fold chambers, and connecting tubes. There are two main types of perfusion
bioreactors: scaffold perfusion and perfusion column. Perfusion columns have
space surrounding the scaffolds, through which the media can flow. By do-
ing this, media is not required to flow throughout the scaffold and therefore
the shear stresses are not as easily controlled, and nutrient delivery is lowered
through the interior porosity of the scaffolds. Scaffold perfusion bioreactors
give better control of shear stresses by flowing media directly through the
scaffolds [6, 83, 41]. This is accomplished by press-fitting the scaffold in a cas-
sette that restricts fluid flow only through the pores of the scaffold, as shown
in Figure 1.4. Assuming pore interconnectivity throughout the scaffold, fluid
flow provides enhanced nutrient delivery to cells residing in all locations of the
construct, and allows for better waste removal as well.
1.3 Benefits of Dynamic Bioreactor Culture
1.3.1 Mass Transfer
The main benefit for utilizing dynamic bioreactor culture is the mitigation
of mass transport limitations. During extended culture, it is necessary to
continually supply the cells with nutrients, such as oxygen and glucose, for
them to continue to proliferate and differentiate. In static culture without
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Figure 1.4: Demonstration of the benefits of a press-fit scaffold perfusion cham-
ber. Fluid is forced to flow through the pores of the scaffold and not in the
space between the scaffold and the chamber wall.
media flow, nutrients are transported to the cells in the interior of the scaffold
mainly by passive diffusion. Previous studies have shown that tissues above
600 µm suffer from large hypoxic areas [67]. Therefore, only cells located near
the periphery of the scaffold will have the nutrients required to proliferate. In
order to culture constructs of clinically relevant size, it is necessary for bone
tissue engineers to develop culture techniques that improve these undesirable
nutrient gradients by adding convective mass transfer.
For the spinner flask bioreactor, the continuous mixing by the drive or
stir bar generate a more homogeneous distribution of nutrients within the
culture system when compared to 3D static culture [81, 64]. While this remains
true for small constructs, this design type struggles to provide nutrients to
the interior of larger scaffolds. As such, diffusion remains the main force for
nutrient transfer in complicated architectures. A study conducted by Shea et
al showed that MC3T3s were not able to penetrate beyond 200 µm into the
scaffold, even after extended culture. Similar to the spinner flask, rotating
wall vessels allow for increased mass transport by exhibiting a laminar flow
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environment, but offer lower overall mass transport benefits for the interior
porosity of the scaffold [64, 35, 80].
In comparison to the previous bioreactor types, perfusion bioreactors pro-
vide enhanced mass transport benefits. Due to the press fit cassettes, media
is not only continuously supplied to the scaffold, but it also forced exclusively
through the interior of the scaffold. By doing this, the nutrient gradient is
mitigated, thus allowing cells to proliferate without experiencing severe hy-
poxic conditions [21, 67, 81, 14]. Furthermore, the unidirectional flow allows
for continual waste removal from the scaffold, unlike the previous two designs.
1.3.2 Shear Stress
In the body, fluid flow induced shear forces give signals to mesenchymal stem
cells to differentiate. As a force is applied to the bone, a pressure change oc-
curs which leads to fluid flow inside the lacunae and canaliculi, leading to a
signal transduction pathway resulting in these stem cells to differentiate into
osteoblasts [21]. In in vitro environments, previous research has shown shear
stresses below 15 dynes/cm2 to have a stimulatory effect promoting osteoblas-
tic differentiation, matrix deposition and calcification, cell proliferation, and
osteogenic gene expression in 3D constructs [21, 76, 74, 66, 65].
In the literature, rotating wall vessels have been shown to provide shear
induced differentiation to cells seeded near the exterior surface at a higher
rate than their spinner flask counterpart [64]. This was evident by an overall
higher expression of alkaline phosphatase and calcium deposition, both com-
mon markers for osteoblastic differentiation. In rotating wall bioreactors, it is
also possible to use numerical models to predict the average stress experienced
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by the scaffold, giving engineers more control [35].
Osteoblastic differentiation is more pronounced in perfusion systems [21,
27, 64]. Again, due to media being forced through the interior of the scaffold,
the average flow induced shear forces are more controllable and more evenly
distributed throughout the scaffold. Bancroft and Sikavitsas investigated the
effects of varying flow rates on osteoblasts in perfusion system [63]. They found
that not only did calcium deposition increase for all perfusion flow conditions
in comparison to static culture, but they also found that it increased with
increasing flow rate. Increasing levels of shear stress can be associated with
increasing flow rate.
As with the rotating wall bioreactor, it is possible to use computational
modeling to predict the localized shear forces within the scaffold. In a series
of studies conducted by Voronov and VanGordon, they not only developed
methods to evaluate the localized fluid shear distributions in scaffolds cul-
tured in perfusion bioreactor systems, but they provided the framework to
predict those values [76, 74, 77, 49, 75]. Most importantly, they found that
constructs with a similar surface area to volume ratio will exhibit similar lo-
calized wall shear stress distributions regardless of the fabrication technique.
From knowing both this and a target stimulatory shear stress, it is possible to
fabricate scaffolds to express, on average, a desired shear value.
1.3.3 Cell Seeding
Cell seeding on a 3D scaffold is the first step in the development of in vitro bone
tissue engineered constructs. Before a tissue can be grown, it is necessary to
adhere cells to the surfaces, both exterior and interior, of the scaffolds, so that
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they may proliferate throughout the construct. In most cases, it is preferable
to have a homogeneous seeding distribution so that the tissue can grow evenly
across the entirety of the scaffold surface area. This is especially true in bone
tissue engineering, where the cells must not only proliferate, but also deposit
mineralized tissue. Cellular adherence is measured by seeding efficiency, which
is the number of cells adhered at the end of a seeding protocol in comparison
to the number of cells that were initially placed on the construct.
Static seeding, or seeding that is not mediated by flow, is largely unsuitable
in terms of seeding efficiency and cell distribtution. In static seeding, cells are
suspended in media and either pipetted onto the surface of the scaffold or the
scaffold is placed into the suspension. There are many techniques employed,
such as vacuum evacuation or shaker plates, to induce cellular migration to the
interior of the scaffold; however, these techniques still lead to nonhomogeneous
tissue development [3, 28, 4, 79], and a higher density of cells on the outside
of the scaffold during extended cultures, which is supported by the literature
[79, 28]. In any case, it is necessary to find alternative methods for effectively
seeding cells.
Dynamic seeding consists of adding the cells in the media, and utilizing
the fluid flow environment available in the bioreactor system to help the cells
navigate to the scaffold surface and potentially to the interior. The addition of
flow produces higher seeding efficiency and a more homogenous cell distribu-
tion [79]. Each of the bioreactor designs presented in this chapter have been
utilized to produce more homogeneous cell distributions with higher initial
seeding efficiencies. Although each of the dynamic bioreactor designs may be
used to accomplish this, the perfusion bioreactor is once again more efficient at
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completing this task [79, 3, 28]. Alvarez et. al. investigating the effectiveness
of oscillatory dynamic seeding in comparison to static seeding for bone tissue
engineering applications [3, 4]. Oscillatory seeded consists of adding the cells
to the media and then using a flow perfusion system to alternate the flow di-
rection making sure that the residence time is adequate to permit cells to fully
travel through the scaffold before flow direction is changed. By doing this,
cells are forced back and forth, through the interior of the scaffold many times
over. They found that by using this method, seeding efficiencies are increased
even more so than with unidirectional flow.
1.4 Analysis Techniques
1.4.1 Imaging Analysis
During bone tissue engineering studies, there are many standardized analyza-
tion techniques in place for evaluating constructs. These break into three
categories: imaging, chemical, and mechanical. Imaging techniques look for
growth, morphology, and distribution. Micro computed tomography (µCT)
and scanning electron microscopy (SEM) are used to evaluate scaffolding, tis-
sue organization, and cell morphology. A comparison of the two methods is
shown in Figure 1.6. µCT is often coupled with mathematical techniques to
evaluate the shear stresses throughout the scaffold [74, 51]. SEM, light mi-
croscopy, and fluorescent microscopy are the most common imaging techniques
used for evaluating tissue. In order to obtain proper images, histology is first
run on the tissue to get viewable cross-sections. It must also be taken into
account that these microscopy-imaging techniques are all destructive.
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Figure 1.5: Micro-computed tomography (left) and SEM (right) images of a
3D printed scaffold. The image on the left was taken during the reconstruction
process using 3D Slicer.
1.4.2 Mechanical and Chemical Analysis
Mechanical evaluation usually consists of testing the mechanical properties
of constructs. This is accomplished by measuring the constructs response to
different levels of stress, strain, and compression. Chemical techniques used
mostly consist of microplate assays. Assays are an easy, but destructive, way
to evaluate cell number, alkaline phosphatase (ALP) activity, calcium pro-
duction for matrix mineralization, and biomolecule markers. Common tests
include DNA, ALP, and calcium assays. If a certain gene is being looked for,
usually for pathway activation, reverse-transcription polymerase chain reac-
tion (RT-PCR) is used. Listed are four expressed genes that may be used to
identify osteoblastic differentiation: Sox9, Runx2, Dlx5, and Twist1. Sox9 is
more commonly associated with chondrocyte development, and regulates the
development of collagen type II. Runx2 has a more direct role in osteoblastic
differentiation. It not only moves cells into becoming osteoblasts, but it also
impedes cells from differentiating into adipocytes or chondrocytes and stops
osteoblastic maturation [10, 36, 23, 1]. Dlx5 is an important gene for axial
and appendicular skeletal formation, and is necessary for chondrocytes turn-
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ing hypertrophic during endochondral ossification [10, 55]. Twist1 increases
the levels of Runx9 expression and studies have also shown that Twist1 sup-
pression leads to abnormal osteoblast activity [10, 22].
1.4.3 Computational Analysis
In order to evaluate the fluid shear fields within scaffolds, previous models,
such as those used by Botchwey et al and Raimondi et al, have used com-
mercial computational fluid dynamics (CFD) programs to run the simulations
using the finite element model. These processes work well for simple scaffolds;
however, when examining the complex scaffolds used currently and factoring
in matrix growth, these methods have not previously worked well [8, 2]. They
mainly suffer from long computational time and are difficult to parallelize mak-
ing them unfit for use in a supercomputer. Advances in distributed computed,
however, has enabled these commercial packages to handle more computation-
ally intensive tasks. Another approach gaining traction involves the use of the
lattice Boltzmann method. This process is inherently parallelizable, deals well
with sophisticated boundaries, and is computationally faster than previous
methods [80].
1.5 Tumor Engineering
During the last decade, the number and effectiveness of in vitro cancer models
have increased dramatically. Utilizing a variety of techniques for 3D culture,
researchers have created models that more closely resemble and predict in vivo
tumor drug responses; however, there is still more room for improvement. In
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particular, these in vitro models consistently exhibit poor cell proliferation
and distribution, which severely limits their predictive capabilities [33]. The
number one hurdle that must be overcome is the development of tumor models
that contain functional vascularization to not only delivery drugs, but also to
deliver nutrients and reduce hypoxia.
During the initial synthesis process, new drugs are usually first tested in
2D cultures before moving on to in vivo animal models; however, these drugs
do not perform the same on 3D cultures as they do in 2D. This is mainly
due to how differently cancer cells behave in 3D, where they express different
surface receptors, proliferation rates, and metabolic functions [33]. Due to
this, 3D in vitro models are an important step between 2D and in vivo cultures
[16, 68, 48, 9, 40]. By first testing drugs in a 3D in vitro model, researchers
can gain better insight as to how the drug will affect 3D tumors before moving
on to more costly and lengthy animal models. Although the funding for cancer
research leads to many new drug therapy studies, the methods for testing these
in vitro lags behind. In particular, a major problem that faces the industry is
the creation of in vitro models that can closely align with in vivo conditions,
and also the ability to grow large tumors that contain functional vasculature.
Above all else, the phenomena of hypoxia is the major obstacle facing the
growth of functional tissues larger than a few millimeters in vitro. In situ
tumors characteristically exhibit hypoxic centers of mass, more dense around
the outer edges. These hypoxic centers induce angiogenesis and the growth
of the tissue [45, 24, 38]. Engineered tumors, however, suffer from a lack
of vascular growth during hypoxia [46]. Due to this, the creation of proper
vascularization in engineered tissues is of utmost importance to researchers.
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Significant progress has been made to alleviate this problem over the past
five years with various methods being developed for testing. However the
scalability of these methods is limited, negating their use in the creation of
larger models. Additionally, they do not allow for intravenous drug testing;
the main method of treating tumors in vivo. The development of constructs
that can support this is necessary for more accurate in vitro drug response
tests.
1.5.1 Importance of 3D Models
The ability to test drugs in vitro is a vital part of new cancer drug therapy
development. It allows for a greater throughput than in vivo testing and is
more cost effective. Though many systems have been proposed, there a few
that are more widely utilized than others. Perhaps the most widely used in
in vitro testing system is the use of multicellular cancer spheroids [38, 25].
These spheroids are large aggregates of cells and usually have diameters of
around 250 µm. They have been widely used due to each individual spheroid
representing a section of tissue that must be penetrated during drug delivery.
The main problems with this method are that the spheroids are not capable
of representing intravenous drug delivery, and each individual spheroid can
only be made at a maximum of 600 µm as an increase leads to necrosis of the
interior.
Another method gaining traction is the development of vascularized tumor
models by using multicell sheet constructs [54]. These consist of creating many
cell monolayers and stacking them on top of a resected vascular network. This
method creates a perfusable system in where the cell sheets are able to receive
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nutrients solely from the vessel network. The downside of the situation is that
the cell sheets are immensely thin, sometimes only a single cell thick, and
stacking takes a considerable amount of time. Currently, only constructs that
are a maximum of 12 sheets thick have been created, only a fraction of the in
vivo equivalents.
A promising technique is to culture tumor cells in 3D polymer scaffolds
in bioreactors [26]. This method is directly analogous to tissue engineering
studies, where stem cells are seeded on the scaffolds and cultured over a period
of time allowing the cells to migrate, and proliferate throughout the construct.
Perfusion bioreactors have proven to be the ideal method for growing these
tumors due to the continuous introduction of nutrients into the system and
subsequent removal of waste products. Of course with this method comes the
basic limitations of growing large tissues in vitro. Once the tumor gains in
size, nutrients are no longer able to penetrate to the interior of the mass due
to the newly formed tissue decreasing the construct porosity and a lack of
vasculature to transport it into the interior. In the absence of oxygen, the
interior of the mass dies from hypoxia, not unlike actual tumors. However
in the case of tumors, this induces vessel formation and the eventual growth
in size. Therefore, these perfusion constructs be forced to create vascular
networks, or we must create the vessels for them.
1.5.2 Current Fabrication Methods
Additive manufacturing, commonly referred to as rapid prototyping or 3D
printing, is a class of material fabrication characterized by the process it cre-
ates 3D models: building up layer by layer. The converse is subtractive manu-
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facturing, which consists of starting with a large block material and removing,
or milling, pieces bit by bit. Common forms of additive manufacturing include
stereolithography, bioprinting, and fused deposition modeling (FDM). In the
interest of scaffold fabrication, the majority of these technologies have been
utilized, but bioprinting and FDM have emerged as the top prospects [12, 70].
Bioprinting, described in the previous section, enables the creation of various
scaffold architectures that are pre seeded with cells, growth factors, or other
additives which has been proven to be of great use for tissue culture. In terms
of vascularization, however, current technologies only allow for either smaller
scale microfluidic chambers to be created, or vessels that exhibit diameters
and pore sizes much larger than in tumors.
FDM has been extensively as a fabrication tool in biomedical research
mainly due to the ease of which it creates complicated 3D structures, includ-
ing scaffolds, with PLLA. Various cell types have successfully been cultured
on PLLA scaffolds created by FDM, some of them for extended periods of
time. These scaffolds exhibit better mechanical integrity than those made
with bioprinting, making it a better candidate for development of vascular
tree networks that can deliver media throughout 3D constructs. It is impor-
tant to note that these same properties make it difficult for cells to rearrange
the fibers, which is an integral step in tissue growth and angiogenesis. There-
fore a coupling of techniques, spunbonded fibers in addition to FDM fibers,
will be used in this proposal. Current fabricated vessels tend to have vessel
diameters of up to 500 µm and pore sizes as low as 10 µm [12, 59, 60, 57, 45].
Though these have shown good results, the vessel dimensions are far cries
from actual tumor vasculature. For prostate cancer, tumors have been shown
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to have vessel diameters of 20-30 µm, and pore cutoff sizes for general tumors
are typically below 2 µm and average around 700 nm [18, 78]. However, recent
advances in FDM such as better drivers and more accurate microstepping, will
allow us to create vessels with greater resolution.
1.5.3 Current Models
As previously stated, the vascularization of in vitro tissues is of utmost im-
portance. To tackle this problem, Okano created vascularized cardiac tissue
by overlaying cellular sheets on top of a perfusable vascular bed [60]. The
vascular networks were resected from rat femoral muscles, decellularized, and
then fixed in a custom-made one pass perfusion bioreactor. The bioreactor was
created so that media was able to be fed into one side of the femoral vessel
and out the other side. The cell sheets were made by co-culturing endothelial
cells (EC) with cardiac cells in temperature responsive culture plates, which
allowed for removal once full confluency was reached.
In order to gain a visual representation of the constructs interior, scanning
fluorescent images were taken of 2D slices. The images presented here show
the locations of the GFP expressing EC and also the locations of additional
vascular networks which have been established after the start of culture. By
perfusing red fluorescent dextran through the vascular bed, researchers were
able to see the growth of vessels throughout the entire construct. An impor-
tant finding was that the development, and subsequent full sheet infiltration, of
blood vessels was intensified when the cell-sheet was cocultured with endothe-
lial cells and/or treated with FGF-2. These induced vessels also resembled in
vivo capillaries which is of great importance for further studies. Unfortunately,
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this method was unable to create tissues of a thickness greater than 12 sheets
thick. Additionally, the vascular network was unable to support the full 12
sheets resulting in a decrease in construct thickness and tissue viability. This
fact leads to the proposed study that will add a more intricate design of the
network in three dimensions.
Spagnoli conducted a study in which they cultured colorectal cancer cell
lines in various environments including perfusion bioreactors [33]. A large
number of cell lines were chosen to provide the community with the knowledge
on how various cancer cell types will perform in perfusion culture. The goal
of the study was to create a tissue like structures that more closely behaved
like their in vivo counterparts when exposed to anti-cancer therapies.
The groups investigated were cells cultured in both static and perfusion
bioreactors, 2D culture, and in vivo. in vivo tumors were induced by injecting
400,000 cells within Matrigel into NMRI-mice. Once the tumor volume reached
6 mm3, the animal was sacrificed and the tumor was removed. After 7 days of
culture, the constructs were evaluated for cell number, cell proliferation, tis-
sue organization through histological staining, and tumor abundance through
histomorphometric analysis. The constructs cultured in perfusion bioreactors
most closely resemble the native tissue. This conclusion is also supported by
both proliferation and apoptotic quantifications. In both cases, the perfusion
constructs exhibited cell numbers directly comparable to the xenografts.
Following tissue culture, chemotherapeutic drugs were administered to each
group in order to compare their drug sensitivity. Since colorectal cancer was
the focus, five agents were used in known effective concentrations. DNA con-
tent was analyzed for each group following 48 or 96 hour incubation periods in
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96 or 12 well plates. Across the board, perfusion constructs exhibited drug sen-
sitivity better than 2D and static 3D cultures, and more similar to xenografts.
They saw limited cytotoxicity, but gene expression showed elevated levels of
cell stress. This study, as a whole, illustrates the ability to culture cells on
3D polymeric scaffolds using flow perfusion bioreactors, and the similarity of
the tissues to native tumors before and after drug delivery. Due to this, we
hypothesize that the development of prevascularized constructs will result in
tissues that exhibit organization and drug response even closer to that of native
tumors.
1.6 Research Objectives
As previously stated, there are three major questions this manuscript aims to
answer: 1) How can we improve both mesenchymal stem cell and cancer cell
adherence to the scaffolds? 2) In terms of flow-induced stresses, what is the
viability of 3D printing for manufacturing repeatable scaffold architectures?
3) Do the shear stresses within a bone tissue engineered construct change over
the culture period? The research objectives listed below give an overview of
each of the studies presented in this manuscript, and are directly coorelated
to one of the above listed questions.
1.6.1 Objective 1
The first objective (Chapter 2) was to develop a functionally flexible surface
modification scheme, and test its effectiveness in increasing MSC attachment
to PLLA scaffolds. The effectiveness of this technique was quantified by ex-
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aming increases in cell spreading and seeding efficiency.
1.6.2 Objective 2
The second objective (Chapter 3) was to leverage the modification scheme de-
veloped in objective 1 to improve cancer cell attachment to PLLA scaffolds.
Like the preceding aim, the effectiveness of this aim was measured by compar-
ing levels of cell spreading and seeding efficiency on the modified scaffolds to
those on nonmodified PLLA scaffolds.
1.6.3 Objective 3
The third objective (Chaoter 4) was to investigate the role of rapid prototyped
scaffold architectures on flow-induced shear stress distributions on the walls
of the scaffold. In particular, we sought to examine 1) the relationship be-
tween the shear distributions in the designed CAD models in comparison to
printed scaffold reconstructions; and 2) the repeatability of shear distributions
in successive printed scaffold reconstructions.
1.6.4 Objective 4
The fourth, and final objective (Chapter 5) was to monitor changes in flow-
induced shear stress distributions on the walls of the scaffold over time in
extended bone culture. This was accomplished using the techniques set in
Objective 3, consisting of µ-CT imaging and FLUENT CFD simulations.
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Chapter 2
Biomimetic Surface
Modification Platform for Bone
Tissue Engineering
Abstract
Tissue engineering utilizes biomaterials, growth factors, and cells (often adult
stem cells) aiming to regenerate damaged tissue or tissue that has been re-
moved. The ability to seed and culture in vitro adult mesenchymal stem
cells (MSC) presents unique challenges due to the inert nature of commonly
used polymeric biomaterials. Mimicking the natural microenvironment of the
target tissue can contribute to improving seeding efficiency and the differen-
tiation of adult stem cells. The choice of scaffold used to support cells in
culture plays a significant role in cell viability and tissue development. Scaf-
fold properties, such as rate of degradation, hardness, and bioactivity must be
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manipulated to match desirable tissue properties and the rate of tissue growth
to scaffold degradation. Unmodified poly(L-lactic acid) (PLLA) scaffolds al-
low consistent cellular proliferation for both 2D and 3D MSC cultures, but
low initial cell attachment rates result in excessive cell loss. Surface modifi-
cation primarily addresses the interface that the cells directly interact with,
coating underlying material that have less desirable properties. Currently,
many varying modificiation techniques exist; however, these suffer from high
cost and low biocomptibility. In this study, we outline a functionally flexible,
biocompatible surface modification scheme for PLLA scaffolds. As a proof of
concept, we modified 2D PLLA films and 3D scaffolds by linking RGD to an
amine-modified surface, then confirmed the extent and longevity of the surface
modification using fluorescent and spectrophotometric chemical markers. The
peptide chain Arg-Gly-Asp (RGD) is known to facilitate cell adhesion. There-
fore, grafting RGD to the surface of a 3D PLLA scaffold should significantly
increase MSC seeding efficiency and potentially improve cell physiology with-
out compromising the mechanical and degradation properties of the underlying
PLLA.
2.1 Introduction
The field of tissue engineering primarily addresses shortcomings in tissue dam-
age repair and organ transplants [13, 20]. By developing techniques for in vitro
tissue culture and development, tissue engineering presents solutions to tissue
This study was completed thanks to the collaborations listed in the acknowledgments.
Listed here are the author contributions: CW performed scaffold fabrication; scaffold func-
tionalization; cell culture; fluorescent staining and imaging; image analysis. NR and MM
assisted in scaffold fabrication, functionalization, and imaging.
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damage-related problems which are unavailable to purely in vivo treatments
[7, 21]. In many cases, treatment for tissue damage involves direct autolo-
gous transplant of a similar tissue from another region within the body. This
approach repairs critically damaged tissue at the cost of tissue strength and
integrity from the donor site. The tissue engineering approach instead ex-
tracts adult stem cells from the host nondestructively. These cells are then
cultured in vitro with scaffolding, media, and flow stresses which mimic an in
vivo environment, allowing the stem cells to proliferate and then differentiate
into cell types which effect the desired tissue. Once properly developed, the
tissue matrix is reinserted at the location requiring tissue repair, providing
both material to provide support and cells optimized to mend the damaged
tissue.
Bone tissue engineering utilizes mesenchymal stem cells (MSC) derived
from bone marrow extract to produce osteoblasts, a key component in bone
development and maintenance [4]. Osteoblastic tissue constructs developed
in vitro will be used as grafts for delayed union or nonunion bone fractures.
Currently, about 1 million delayed union or nonunion fractures occur in the
U.S. each year. Standard treatment for these conditions involve an autologous
bone graft, usually bone material removed from the hip. This method creates
significant risk of morbidity and infection at the donor site as well as reducing
the mechanical integrity of the hip bone. Development of a similar graft from
MSCs would circumvent these complications [5].
The properties of the scaffold that supports the stem cells play a significant
role in cell growth and differentiation and tissue development [9, 17, 19, 8, 23,
24, 11, 14]. As the supporting structure, the scaffold needs an appropriate
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degree of rigidity for the target tissue. Bone tissue in particular requires rigid
scaffolding. Additionally, scaffolding requires porosity or maximal surface area
for nutrient transfer and cell expansion. Scaffolds must also promote cell
adhesion or they would not be viable surfaces for cell culture. When exposed
to the tissues native conditions, the scaffold must degrade at a rate similar
to tissue development into a non-toxic product. These and other necessary
and optimizable constraints place scaffold design as a central aspect of tissue
engineering.
In bone tissue engineering, inoculation of MSCs onto poly (L-lactic acid)
(PLLA) scaffolds results in well-documented setbacks in cellularity and cell
development [9, 19, 23]. Static seeding efficiencies average about 10% cell ad-
herence. Methods of flow perfusion of cells suspended in media through 3-D
scaffolds increase efficiencies to 30-40%. Though a significant improvement
over static seeding, this approach requires extensive seeding periods and com-
plex bioreactor design. The majority of cells are still flushed away without
adhering. Secondarily, due to an adjustment period known as the lag phase,
cell number drops over the first 24 hours as pioneer cells dedicate more energy
to developing extracellular matrix (ECM). While the establishment of ECM
allows surviving cells to grow more easily with recognizable morphologies, the
energy cost of producing the ECM upon adhering to a novel surface extends
the timeline between marrow extraction and fracture treatment.
Modification of the scaffold to create a surface that enhances cellular ad-
herence and extracellular matrix generation directly addresses these limita-
tions [12, 1, 2, 24, 10, 15, 14, 16, 25]. These modified surfaces contain ECM
molecules and derivatives that have been found to improve cell recognition
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of the surface and present a hydrophilic interface for cells. Although several
methods for surface modification have been tested, plasma treatment has been
the primary method. However, this method has some difficulty in modifying
internal surfaces in a 3D scaffold, and plasma exposure may alter mechani-
cal properties of the underlying PLLA [6, 20]. The former limitation renders
the plasma treatment method incompatible with 3D-scaffold flow perfusion
bioreactors that subject the scaffold and cells to shear stresses similar to those
present in bone structures, because cells in the interior of the scaffold will be
detached. If a method for surface modification could attach biomolecules via
surface interactions with a liquid solution rather than plasma exposure, then
the surfaces could be biomolecule-functionalized without mechanical alteration
of the interior PLLA structure.
As an alternative to polyK, in this study, small MW amine-terminated
PLLA polymer were introduced to semi-permeabilized 2D and 3D PLLA scaf-
folds (Figure 2.1) [2]. Briefly, amine-terminated PLLA was physically en-
trapped on the surface of the scaffolds. Amine-modified surfaces were then
crosslinked to arginine-glycine-aspartic acid (RGD) peptides using N-succinimidyl
3-(2-pyridyldithio) propionate (SPDP). Amine surface-coverage and RGD-
binding were analyzed to validate the completeness and longevity of the surface
modification process.
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Figure 2.1: Basic amine entrapment reaction scheme. The scheme consists of
the following steps: (1) physical entrapment of amine terminated PLLA on
the scaffold surface, (2) crosslinking using SPDP through amine coupling, (2)
RGDC functionalization using sulfur-sulfur bonding. Verification of each step
shown in Figures 2.2, 2.4, and 2.7, respectively.
2.2 Materials & Methods
2.2.1 Film Preparation
2D polymer films were prepared by dissolving poly(L-lactic acid) (PLLA)
(Natureworks; average MW of 100000) pellets in chloroform (Sigma-Aldrich).
PLLA pellets were dissolved in chloroform at a concentration of 0.1 g/mL and
then poured into either 35 mm or 75 mm dishes to form a thick or thin liquid
film, respectively. These liquid films were then allowed to dry over 24 hours.
Once dry, films were removed from the dishes and stored under vacuum until
needed.
2.2.2 Scaffold Manufacturing
Poly(L-lactic acid) (PLLA; grade 6251D; 1.4% D enantiomer; 108,500 MW;
1.87 PDI; NatureWorks LLC) nonwoven fiber mesh scaffolds were produced
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via spunbonding, as previously indicated from previous studies [23]. Scaffolds
were cut from an 8mm thick PLLA mat, resulting in scaffolds of 88% porosity.
A Nikon HFX-II microscope was used to evaluate fiber diameter, found to
be 24.5 µm, and was confirmed by scanning electron microscopy. The pore
size was determined in previous studies to be around 250 µm (120), and was
confirmed by scanning electron microscopy.
3D printed scaffolds were designed custom to provide maximum nutrient
penetration. 8 mm diameter cylinders were designed (SolidWorks, Waltham,
MA), and sliced to produce a 65% porous fiber network (Simplify3D). Fol-
lowing slicing, scaffolds were printed at the following conditions: extruder
temperature (215oC), print head speed (150 mm/s), and a layer height (0.10
mm) on a Makerbot 5th Generation Replicator (Makerbot, Inc). Scaffolds
were printed on Kapton tape (McMaster-Carr) to allow adhesion to the build
plate during printing and easy removal after post-curing. Pore size and fiber
diameter were measured using the technique listed in the following section.
2.2.3 Porosity Measurements
Porosity was quantified (n = 12 per group) using gravimetric analysis follow-
ing previous methods [18]. Briefly, sample dimensions (length, L; width, W;
thickness, T) and weight (wscaffold) were measured and used to calculate the
porosity () according to Equation 1, where ρscaffold is the scaffold density and
material is the density of the material.
 = 1− ρscaffold
ρmaterial
= 1− wscaffold
LWTρmaterial
(2.1)
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2.2.4 Modification Process
Bulk modification of the films began with dissolving both amine-terminated
poly (L-lactic acid) (Sigma Aldrich; average MW 2500) and PLLA into chlo-
roform at concentrations of 0.01 g/mL and 0.09 g/mL respectively. Then films
were made in either 35 mm or 75 mm dishes as outlined above. Surface mod-
ification of the films began with pure PLLA films. Films were rinsed with
phosphate-buffered saline (PBS) then incubated in 1 mL of 70% acetone in
water for 1 h with moderate shaking, while scaffolds were modified in 2 mL.
The acetone mixture was then aspirated and films were incubated in 1 mL of
DMSO with 0.2 mg/mL small MW amine-terminated PLLA for 12 h again
with moderate shaking, with scaffolds again being incubated in 2 mL. After
that, films and scaffolds were rinsed with DI H2O and left to vacuum dry for 24
h. The water rinse insures the short chain amine terminated PLLA is caught
in the surface of the long chain PLLA.
Following bulk or surface small MW amine-terminated PLLA modification,
functionalization was completed through the chemical linking of N-succinimidyl
3-(2-pyridyldithio) propionate (SPDP) (Thermo Scientific) and Arg-Gly-Asp-
Cys peptide (RGDC) (Bachem) to the surface, shown in Figure 1. Films were
rinsed with PBS then incubated at 25 oC on a shaker in 1 mL of 0.04 mmol/mL
SPDP in DMSO diluted with PBS to 0.01 mmol/mL SPDP with a pH of 7.4
for 30 min. SPDP solution was aspirated and films were incubated at 40oC in
1 mL of 0.045 mg/mL RGDC in HEPES solution with a pH of 8.3 for 90 min.
Films were then rinsed with PBS and left to vacuum dry for 24 hours before
chemical sterilization.
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2.2.5 Fluorescent Surface Amine Analysis
NHS rhodamine was used to determine the surface concentration of primary
amine groups following initial small MW amine-terminated PLLA surface or
bulk modification. Films were incubated at 25 oC on a shaker plate in 1 mL of
0.2 mg/mL NHS rhodamine in PBDS for 30 minutes, while scaffolds underwent
the same rinses in 2 mL of solution. They were then rinsed with 15 min
periods on the shaker plate in 1% PBST followed by two DI H2O rinses. Each
sample was imaged on a Nikon Eclipse E800 microscope. Fluorescent intensity
was quantified using ImageJ image analysis software. Surface modified films
were compared to bulk modified films as a control for surface presence and
distribution of small MW amine-terminated PLLA.
2.2.6 Spectrophotometric RGDC Binding Analysis
The SPDP linkage with RGDC was confirmed using spectrophotometry of
the HEPES media following the RGDC incubation period. As the reaction
proceeds, pyridine 2-thione is released from the SPDP molecule.
2.2.7 Cell Expansion and Seeding
Adult mesenchymal stem cells were extracted from the tibias and femurs of
male Wistar rats (Harlan Laboratories) using methods identified in previous
publications [22, 1]). Cells were cultured at 37 oC, and 5% CO2 in standard
α-MEM (Invitrogen) supplemented with 10% fetal bovine serum (Atlanta Bio-
logicals) and 1% antibiotic-antimycotic (Invitrogen). Passage 2 cells were used
for this study at a density of 2 million cells/mL for scaffold seeding.
We prepped the scaffolds for cell seeding using an established pre-wetting
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technique [2]. Vacuum air removal of scaffolds was conducted in 75% ethanol.
Pre-wet scaffolds were placed in cassettes within a flow perfusion bioreactor
for one hour in α-MEM at a flow rate of 0.15 mL/min to remove any remaining
ethanol [18, 3]. Following the flush, 2 million MSCs/150 µL of α-MEM were
pipetted in each each scaffold chamber. After seeding, the bioreactor was
allowed to rest for two hours, without flow, to facilitate cell attachment.
2.2.8 Construct Cellularity
The number of cells present in each construct was evaluated using fluorescent
PicoGreen dsDNA assay (Invitrogen). At each sacrificial time point, the con-
struct was removed from the cassette and dunked in PBS to remove any cells
not adhered to the scaffold. Subsequently, the scaffolds were chopped into
eight pieces, placed in 1 mL of DI H2O, and stored at -20
oC. Each construct
underwent three freeze/thaw cycles to lyse the cells. After following supplier
protocols, solutions were run on a Synergy HT Multi-Mode Microplate Reader
(Bio-Tek) at an excitation wavelength of 480 nm and an emission wavelength
of 520 nm. All samples and standards were run in triplicate.
2.2.9 Fluorescent Nucleus and Actin Staining
Three scaffolds at each time point were subjected to hoechst and phallacidin
staining. This was done to confirm the cellularity result from the above ds-
DNA assay as well as to provide information on cell distribution within the
scaffold in addition to matrix deposition. Scaffolds were resected from culture,
rinsed with PBS, and fixed in solution of 4% formalin in PBS for 15 minutes
at 25 oC. Following this, samples were rinsed in three consecutive PBS washes.
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They were then permeabilized in a solution of 0.5% PBST (PBS and Triton
X-100) for 15 minutes at 25 oC. Fixed and permeabilized samples were stained
using hoechst 33342 and phalloidin (ReadyProbes NucBlue and ActinGreen
488; Thermofisher Scientific) using manufacturer protocols. After incubation,
scaffolds were rinsed thoroughly with PBS before imaging on a Nikon Epi-
fluorescence microscope. Image analysis was performed with MetaMorph 6.2
(Universal Imaging Corporation) and Image J software packages.
2.2.10 SEM Preperation and Imaging
Samples were prepared for SEM imaging by rinsing them in PBS after remov-
ing from culture. These samples were then fixed overnight in 4% formalin
at 25 oC. Following fixation, samples were rinsed in ethanol concentrations
ranging from 70% to 100%. Samples were then removed from solution and
allowed to dry for 48 hours under vacuum. After mounting to SEM mounts,
the samples were sputter-coated in gold palladium using a Hummer VI Triode
Sputter Coater (Anatech Ltd.). SEM images were produced using a Zeiss 960
scanning electron microscope (SEM, Carl Zeiss SMT Inc) at 15kV. Digital
images were captured using EDS 2006 and EDS 2008 digital imaging software
(IXRF Systems).
2.2.11 Statistical Analysis
A one-way analysis of variance (ANOVA) was used to compare mean ± stan-
dard deviation of pore and fiber measurements, in which Tukeys Honestly
Significant Difference (HSD) test was performed to identify significant dif-
ferences (p-value < 0.05). One-way ANOVA and Tukeys HSD were used to
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compare the rest of the data. All statistical analysis was performed using a
custom python code utilizing the open source Numpy, matplotlib, and SciPy
libraries.
2.3 Results
2.3.1 Surface Activity
Validation of the physical entrapment of the small MW amine-terminated
PLLA on the surface was performed initially using the NHS rhodamine flu-
orescent probe for primary amine groups. Films modified with 0.2 mg/mL
small MW amine-terminated PLLA in DMSO and unmodified PLLA films
were imaged with and without NHS rhodamine treatment following 7 days
of vacuum storage. Bulk modified films are shown in Figure 2.2, and surface
modified films are shown in Figure 2.3. Unmodified films showed a statistically
negligble amount of fluorescence. The modified film displayed pervasive fluo-
rescence while the control film displayed mild dispersed fluorescence indicative
of low-level physisorption of the NHS rhodamine probe. No untreated samples
demonstrated fluorescence. Modification of 3D scaffolds was also observed us-
ing 3D-printed PLLA scaffolds. Images indicate similar surface coverage of the
modified scaffold and minor physisorption on the unmodified scaffold (Figure
2.3). A bright field image of the unmodified scaffold was taken as reference for
the structure of the 3D-printed scaffold.
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Figure 2.2: Fluorescent micrographs of surface verification treated with NHS
rhodamine demonstrating the presense of amine groups on 2D PLLA films.
(A): unmodified. (B): acetone soak without amine-terminated PLLA (C): full
modification (D): acetone soak with amine-terminated PLLA with H2O. Scale
bar is 1000 µm.
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Figure 2.3: Fluorescent micrographs of surface verification treated with NHS
rhodamine demonstrating the presense of amine groups on 3D printed scaf-
folds. (A): unmodified. (B): acetone soak without amine-terminated PLLA
(C): full modification (D): acetone soak with amine-terminated PLLA with
H2O. Scale bar is 1000 µm.
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2.3.2 Surface Modification Validation
Completion of the surface modification process was confirmed using spec-
trophotometric analysis of the solutions used in the reactions, shown in Figure
2.4. For each solution, six samples were taken (n = 6). The first solution was
a 1 ml PBS rinse of a small MW amine-terminated PLLA modified film. The
second solution was 1 ml of RGDC in HEPES solution exposed to an small
MW amine-terminated PLLA modified film. The third solution was 1 mL of
the SPDP solution exposed to a small MW amine-terminated PLLA modified
film. The fourth solution was 1 mL of RGDC in HEPES solution exposed to
an small MW amine-terminated PLLA+SPDP modified film. This solution
displayed a significant increase in absorbance (p < 0.01) due to the release of
pyridine 2-thione when SPDP reacts with the sulfhydryl in RGDC.
2.3.3 Surface Modification Longevity
With vacuum preservation, the initial physical entrapment of small MW amine-
terminated PLLA will maintain consistent surface coverage for a period of
over a week. For 7 days following small MW amine-terminated PLLA sur-
face modification, scaffold samples were analyzed for fluorescent intensity to
determine the longevity of the physical entrapment (Figure 2.5). Samples dis-
played fluorescent intensity within 20-25 units with no significant decrease as
time progressed.
2.3.4 Surface Concentration Control
Figure 2.6 shows the fluorescent dual staining of cell seeded 2D films and Figure
2.7 compares the surface area per cell with varying surface concentrations of
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Figure 2.4: Detection of pyridine-2-thione released during the modification
process with different techniques. When SPDP linked to the aminated surfaces
is reacted with a secondary peptide it releases pyridine-2-thione, developing
a green color whose absorbance can be read at 405 nm. The dotted line
represents the baseline absorbance of PLLA. Values are given as the mean ±
standard error of the mean (n = 3). Significance is indicated by ∗ (p < 0.01).
Figure 2.5: Surface activity of aminated surfaces over one week for surface
modified versus bulk modified methods. When NHS rhodamine is reacted
with each construct prior to fluorescent imaging, it attaches to free amine
groups, which can be quantified using fluorescent imaging. Values are given
as the mean ± standard error of the mean (n = 3).
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Figure 2.6: Fluorescent dual staining of fixed MSCs. Stains were completed
using hoechst and phallacidin to stain the cell nucleus and actin, respectively.
RGD. Error bars are shown, but are so small they are difficult to see. It is
evident that there is a continual increase in cell surface area with surface area.
The drop at a concentration of 10−1 can be attributed to cell death due to
over stimulation by RGD, which has been discussed in the literature [2].
2.4 Discussion
In order to validate the functionalization process, films and scaffolds were
prepared that contained the free terminal amine groups. The samples were
incubated with NHS rhodamine, a fluorescent amine coupling tag. Figure 2.2
and Figure 2.3 show the results of this process. The control groups (A-C)
express little to physisorption indicating no free amine groups are expressed;
while the amine functionalized group (D) shows a clear fluoresence indicating
free amine groups are expressed on the surface. This result shows a successful
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Figure 2.7: Effect of the extent of amine-terminated entrapment on mesenchy-
mal stem cell surface area after linkage of arginineglycineaspartic acidcysteine
(RGDC) peptides to amine groups entrapped in poly(L-lactic acid) discs. The
concentrations listed are amount of RGD in solution that were available for
reaction. Controls (striped lines) indicate scaffolds that were amine-modified
only. The dotted line represents the baseline absorbance of PLLA. Values are
given as the mean ± standard error of the mean (n = 3). & signifies the sig-
nificantly lowest value. Significance calculated via ANOVA with Tukey HSD
Post-hoc analysis.
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amine termination scheme.
To test the viability of the second modification stage, levels of pyridine-2-
thione were measured. This fluorescent moiety is released following complete
SPDP conjugation. Samples were modified using the complete process: includ-
ing amine termination, SPDP crosslinking, and RGD functionalization, with
the samples being measured from the reaction solution. As shown in Figure
2.4, there is a stasticially signigicant elevation of pyridine-2-thione released
following RGD functionalization. This same elevation is not seen in following
the intermediate steps, equating to no activiation of pyridine-2-thione release.
Again, this result indicates the successful binding of RGDC to those afore-
mentioned free amines.
Additionally, surface longevity of free amine expression was measured.
Films and scaffolds were modified to express free amines. Those samples were
then stored under vacuum for up to 7 days to allow for amine release. One
week was chosen for testing due to this being the minimal time necessary for
an off the shelf material to be adopted for clinical use according to our market
research. Before testing, samples were rinsed in DI H2O and dried under vac-
uum. Following this, samples were incubated in NHS rhodamine and imaged
by fluorescent microscopy, where Figure 2.5 shows the results of this process. It
is evident from the results, that surface modification expresses higher amounts
of amine termination over the tested time frame in comparison to bulk mod-
ification. A large drop off between Days 1 and 2 is seen before intesity levels
off. We believe this decrease is due to shallow amine group penetration during
the modification process, which quickly falls off. This is supported by the bulk
results, which to do exhibit the same initial drop off. In fact, bulk modification
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amine intensity levels remain constant throughout the 7 days indicating very
strong binding.
Finally, the surface area per cell, or cell stretching, was investigated for
varying levels of RGD modficiation. The surface area per cell is a measure of
the actin and nucleus surface area normalized for the number of cells on the
surface. This measurement is a common method of quantifying the strength of
cellular binding to a surface. Figure 2.7 shows an increase of cell spreading as
the amount of RGD modification is increased. This fact shows that by using
our modification process, we are able to tightly control the extent of RGD
modification, and, by extension, the strength of cell adhesion. We attribute
the decrease in cell spreading at 10−1 to be associated with over stimulation
of the cells resulting in cell death and detachment, which has been previously
reported as a negative effect of RGD [2].
2.5 Conclusion
In this study we aimed to develop a physical entrapment surface amination
technique for PLLA scaffolds that took advantage of PLLAs partial solubi-
lization in acetone. We improved upon past work by using amine-terminated
PLLA, a simple molecule with a single functional primary amine attached
to a short chain of PLLA as opposed to previously employed Poly--Cbz-L-
lysine which does not meet FDA clinical standards. By introducing small MW
amine-terminated PLLA during the acetone soak, we also removed the DMSO
soak which may have resulted in physical entrapment of DMSO molecules and
supported further undesirable surface modifications. DMSO has also been ef-
fectively removed from the subsequent covalent modifications by the use of an
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acetone + SPDP crosslinker soak. The physical entrapment method of surface
modification of PLLA scaffolds results in thorough coverage on both 2D films
and 3D scaffolds. In vacuum conditions, this modification resists degradation
up to 7 days. Significant binding of the desired protein takes place on this
surface. Lastly, we are able to tightly control the strength of cell adhesion to
the modified surface by varying the extent of RGD functionalization.
Future work will quantify surface concentrations of the modifications and
degradation over a greater period of time. The amination technique will be
applied to 3D PLLA scaffolds to determine penetration into the inner surfaces,
and cells will be cultured under shear stresses from flow perfusion of media,
replicating blood flow through bone tissue. Cell morphology, migration, and
differentiation will be considered in response to the modifications. Finally,
cells will be cultured on modified films for longer periods of time to analyze
the transition from designed biomimetic surfaces to deposited ECM.
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Supplemental Figures
Figure 2.8: Fluorescent micrographs of bulk modified films using NHS rho-
damine. (A): unmodified. (B): modified. Unmodified indicates plain PLLA.
Modified indicates films that have been functionalized to express free amine
groups.
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Chapter 3
N-Cadherin Mediated
Enhancement of Cancer Cell
Adhesion on Poly(l-lactic acid)
Scaffolds under Flow Perfusion
for the Development of in vitro
Tumor Models
Abstract
During the last decade, the number and effectiveness of in vitro cancer models
have increased dramatically. Utilizing a variety of techniques for 3D culture,
researchers have created models that more closely resemble and predict in
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vivo tumor drug responses; however, there is still more room for improvement.
In particular, these in vitro models consistently exhibit poor cell prolifera-
tion and distribution, which severely limits their predictive capabilities. The
number one hurdle that must be overcome is the poor adhesion that cancer
cells have to non hydrogel scaffolds, which severely limits the development of
tumor models that contain fully developed tissue. To combat this, we have
successfully seeded various cancer cell lines (PC3, MDA, and B16) on three
dimensional poly (l-lactic) acid scaffolds, and cultured them for up to three
weeks in perfusion bioreactors with samples taken intermittently. By using
oscillatory seeding and surface modifications, we are able to increase seeding
efficiency and, subsequently, the distribution of cells throughout the construct.
Through the use of biochemical assays, fluorescent imaging, and µCT we are
able to identify that these constructs behave more closely to native cancer
tissue.
3.1 Introduction
During the initial synthesis process, new drugs are usually first tested in 2D
cultures before moving on to in vivo animal models; however, these drugs do
not perform the same on 3D cultures as they do in 2D. This is mainly due to
how differently cancer cells behave in 3D, where they express different surface
receptors, proliferation rates, and metabolic functions [11]. Due to this, 3D
in vitro models are an important step between 2D and in vivo cultures. By
This study was completed thanks to the collaborations listed in the acknowledgments.
Listed here are the author contributions: CW performed scaffold fabrication; scaffold func-
tionalization; cell culture; fluorescent staining and imaging; image analysis. PM performed
fluorescent staining and imaging. and MM assisted in scaffold fabrication, functionalization,
and imaging.
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first testing drugs in a 3D in vitro model, researchers can gain better insight
as to how the drug will affect 3D tumors before moving on to more costly
and lengthy animal models. Although the funding for cancer research leads
to many new drug therapy studies, the methods for testing these in vitro lags
behind. In particular, a major problem that faces the industry is the creation
of in vitro models that can closely align with in vivo conditions, and also the
ability to grow large tumors.
Above all else, the phenomena of hypoxia is the major obstacle facing the
growth of functional tissues larger than a few millimeters in vitro. In situ
tumors characteristically exhibit hypoxic centers of mass, more dense around
the outer edges. These hypoxic centers induce angiogenesis and the growth
of the tissue [7]. Engineered tumors, however, suffer from a lack of vascular
growth during hypoxia [8]. Due to this, the creation of proper vascularization
in engineered tissues or utilizing flow systems that maximize nutrient deliver.
Significant progress has been made to alleviate this problem over the past
five years with various methods being developed for testing [6, 14, 13, 5, 9].
However the scalability of these methods is limited, negating their use in the
creation of larger models.
A promising technique is to culture tumor cells in 3D polymer scaffolds in
bioreactors [7, 8, 11]. This method is directly analogous to tissue engineering
studies, where stem cells are seeded on the scaffolds and cultured over a period
of time allowing the cells to migrate, and proliferate throughout the construct.
Perfusion bioreactors have proven to be the ideal method for growing these
tumors due to the continuous introduction of nutrients into the system and
subsequent removal of waste products. The limiting factor for this method is
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initial cellular adhesion. When compared to mesenchymal stem cells, cancer
cells exhibit significantly lower adhesion rates. This fact means that it will
take significantly longer to culture a dense tissue.
To combat this major issue, we have leveraged our patented biomimetic
surface modification platform for tumor engineering applications. In partic-
ular, we have identified various moieties specific to certain tumors that are
integral to cellular adhesion, and have used these to modify our scaffolds and
trick the cancer cells into exhibiting higher rates of adhesion. For instance, in
terms of prostate cancer, poly(L-lactic acid) (PLLA) scaffolds were modified
to express n-cadherin, which is a highly upregulated protein used for cellular
adhesion. N-cadherin has been shown to be very important in tumors with
metastatic potential by contributing to both cell-to-cell adhesion (Figure 3.1),
and osteoblastic differentiation in stem cells (Figure 3.2). Most importantly
for tumor cell adhesion, its role is the activation of β-catenin, a major player
in Wnt signaling. This activation will allow for α-catenin to attach to the non
dominant binding site on β-catenin’s ARM domain. The role of α-catenin is
to attach directly to actin filaments, increasing cell adhesion. For the study as
a whole, we will be seeding various cancer cell lines (PC3, MDA, and B16) on
both 2D and 3D PLLA scaffolds, and culturing them under increasing shear
levels in perfusion bioreactors with samples taken intermittently. Through
the use of various biochemical assays, fluorescent microscopy, and µCT we
identified that these constructs behave more closely to native cancer tissue in
comparison to those grown using non-functionalized scaffolds. After cell seed-
ing, we were able to significantly increase seeding efficiency and potentially
improve cell physiology without compromising the mechanical and degrada-
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tion properties of the underlying PLLA.
3.2 Materials & Methods
3.2.1 Film Preparation
Poly(L-lactic acid) (Natureworks; average MW 100,000) films were prepared by
dissolution of PLLA pellets in chloroform followed by evaporative deposition.
PLLA pellets were dissolved in chloroform at a concentration of 0.1 g/mL
and then poured into 35 mm dishes to form a liquid film and dry over 24
hours. Once dry, films were removed from the dishes and kept in a pressurized
chamber until use.
3.2.2 Scaffold Manufacturing
Poly(L-lactic acid) (PLLA; grade 6251D; 1.4% D enantiomer; 108,500 MW;
1.87 PDI; NatureWorks LLC) nonwoven fiber mesh scaffolds were produced
via spunbonding, as previously indicated from previous studies [16]. Scaffolds
were cut from an 8mm thick PLLA mat, resulting in scaffolds of 88% porosity.
A Nikon HFX-II microscope was used to evaluate fiber diameter, found to be
24.5 µm, and was confirmed by scanning electron microscopy.
3D foam scaffolds were made using solvent-cast porogen-leaching [3, 12].
Breifly, PLLA pellets were dissolved in chloroform at a concentration of 0.1
mg/mL. NaCl was sieved to obtain grains between 250-350 µm (Sigma-Aldrich).
Following this, up to 5 g of NaCl was poured in 35 µm or 75 µm glass petri
dishes. After making an even bed of salt grains, the PLLA solution was poured
over the bed, and the dishes were allowed to dry for 24 hours.
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Figure 3.1: N-Cadherin signaling pathway, through the canonical WNT sig-
naling pathway [Sino Biological, Inc.].
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Figure 3.2: N-Cadherin osteoblastic differentiation signaling pathway. [Marie
2009]
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Following drying, the beds were divided into 2.5 g aliquots. These aliquots
were placed in custom milled 8 mm mold and compressed at 500 psi. During
compression, the molds were heated to 130 0C, and held at constant pressure
and temperature for 30 minutes. Following this process, the compressed PLLA
was punched from the mold. Using a diamond saw (Model 650, South Bay
Technology, Inc.), the rods were cut into 2.3 mm thick disks. The disks were
placed in deionized water under agitation for 48 hours to leach out the NaCl,
with DI water replaced twice daily. Following the leaching process, scaffolds
were placed under vacuum to dry for 24 hours. The resulting scaffolds were
2.3 mm thick, 8 mm diameter, and ∼85% porous.
3.2.3 N-Cadherin Functionalization
Surface modification of the films began with pure PLLA films. Films were
rinsed with phosphate-buffered saline (PBS) then incubated in 1 mL of 70%
acetone in water for 1 h with moderate shaking, with scaffolds being incubated
in 2 mL. The acetone mixture was then aspirated and films were incubated in
1 mL of DMSO with 0.2 mg/mL small MW amine-terminated PLLA for 12
h again with moderate shaking, and scaffolds in 2 mL. After that, films and
scaffolds were again rinsed with PBS and left to vacuum dry for 24 h.
Following surface amine termination modification, amine-amine mediated
functionalization was completed through the chemical linking of N-succinimidyl
3-(2-pyridyldithio) propionate (SPDP) (Thermo Scientific) and human n-cadherin
(Sino Biological) to the surface. Films were rinsed with PBS then incubated
at 25 oC on a shaker in 1 mL of 0.04 mmol/mL SPDP in DMSO diluted with
PBS to 0.01 mmol/mL SPDP with a pH of 7.4 for 30 min, and scaffolds were
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incubated in 2 mL. SPDP solution was aspirated and scaffolds were incubated
at 25oC in 2 mL of 2.5 mg/mL n-cadherin in PBS with a pH of 7.4 for 30 min,
with films being incubated in 600 600 µL. Scaffolds and films were then rinsed
with PBS and left to vacuum dry for 24 hours before chemical sterilization.
Carboxyl-amine mediated functionalization was completed through EDC
carbodiimide crosslinker (Thermofisher Scientific) and human n-cadherin (Sino
Biological) to the surface. Briely, n-cadherin was incubated in an activation
buffer at a concentration of 1 mg/mL at 25 oC. Activation buffer consists of
0.1M MES and 0.5M NaCl in PBS at a pH of 6.0. Following this, 0.4 mg
EDC (∼2mM) and 0.6mg of NHS were added to the solution and allowed to
react for 15 minutes at 25 oC. Finally scaffolds were incubated in 2 mL of this
solution (films in 600 µL) for 2 hours at 25 oC to facilitate complete reaction.
Scaffolds and films were then rinsed with PBS and left to vacuum dry for 24
hours before chemical sterilization.
3.2.4 Cell Expansion and Seeding
Adult mesenchymal stem cells were extracted from the tibias and femurs of
male Wistar rats (Harlan Laboratories) using methods identified in previous
publications [15, 1]). Cells were cultured at 37 oC, and 5% CO2 in standard
α-MEM (Invitrogen) supplemented with 10% fetal bovine serum (Atlanta Bio-
logicals) and 1% antibiotic-antimycotic (Invitrogen). Passage 2 cells were used
for this study at a density of 2 million cells/mL for scaffold seeding.
PC3 prostate cells, B16 melanoma cells, and MDA breast cancer cells
(ATCC) were cultured in T75 culture flasks using manufacturer recommended
culture medium. PC3 and B16 cells were cultured in RPMI and MDA cells
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were cultured in L-15. Cells were cultured until reaching 70% confluency, and
then were lifted and suspended at a density of 1 million cells/mL for scaffold
seeding.
We prepped the scaffolds for cell seeding using an established pre-wetting
technique [2]. Vacuum air removal of scaffolds was conducted in 75% ethanol.
Pre-wet scaffolds were placed in cassettes within a flow perfusion bioreactor
for a one hour in α-MEM to remove any remaining ethanol [10, 4]. Following
the flush, 1 million MSCs, PC3s, B16s, or MDAs in 150 µL of media were
pipetted in each each scaffold chamber. The seeding mixture was dynamically
perfused at 0.15 mL/min, forwards and backwards, in five minute intervals
for two hours. After oscillatory seeding, the bioreactor was allowed to rest for
two hours, without flow, to facilitate cell attachment. Finally, the appropriate
media was continuously perfused at a rate of 0.5 mL/min/scaffold.
3.2.5 Construct Cellularity
The number of cells present in each construct was evaluated using fluorescent
PicoGreen dsDNA assay (Invitrogen). At each sacrificial time point, the con-
struct was removed from the cassette and dunked in PBS to remove any cells
not adhered to the scaffold. Subsequently, the scaffolds were chopped into
eight pieces, placed in 1 mL of DI H2O, and stored at -20
oC. Each construct
underwent three freeze/thaw cycles to lyse the cells. After following supplier
protocols, solutions were run on a Synergy HT Multi-Mode Microplate Reader
(Bio-Tek) at an excitation wavelength of 480 nm and an emission wavelength
of 520 nm. All samples and standards were run in triplicate.
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3.2.6 Fluorescent Nucleus and Actin Staining
Three scaffolds at each time point were subjected to hoechst and phallacidin
staining. This was done to confirm the cellularity result from the above ds-
DNA assay as well as to provide information on cell distribution within the
scaffold in addition to matrix deposition. Scaffolds were resected from culture,
rinsed with PBS, and fixed in solution of 4% formalin in PBS for 15 minutes
at 25 oC. Following this, samples were rinsed in three consecutive PBS washes.
They were then permeabilized in a solution of 0.5% PBST (PBS and Triton
X-100) for 15 minutes at 25 oC. Fixed and permeabilized samples were stained
using hoechst 33342 and phalloidin (ReadyProbes NucBlue and ActinGreen
488; Thermofisher Scientific) using manufacturer protocols. After incubation,
scaffolds were rinsed thoroughly with PBS before imaging on a Nikon Epi-
fluorescence microscope. Image analysis was performed with MetaMorph 6.2
(Universal Imaging Corporation) and Image J software packages.
3.2.7 Statistical Analysis
A one-way analysis of variance (ANOVA) was used to compare mean ± stan-
dard deviation of pore and fiber measurements, in which Tukeys Honestly Sig-
nificant Difference (HSD) test was performed to identify significant differences
(p-value < 0.05). One-way ANOVA and Tukeys HSD were used to compare
the rest of the results. All statistical analysis was performed using a custom
python code utilizing the open source Numpy, matplotlib, and SciPy libraries.
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Figure 3.3: Dual staining of fixed B16 cells seeded on PLLA scaffolds with
cell nuclei show in blue and actin shown in green. The left image features
unmodified PLLA; the right, modified. Stains were completed using hoechst
and phallacidin to stain the cell nucleus and actin, respectively.
3.3 Results
3.3.1 Surface Activity
Validation of cell seeding following modification was evaluated on 2D films.
Figure 3.3 shows B16 cells seeded on unmodified and modified PLLA films.
Clearly, cells seeded on modified surfaces express a higher degree of cell at-
tachment.
3.3.2 Surface Modification Validation
Completion of the modification process was confirmed using through the com-
parison of cell spreading for plain, a negative control, and a positice control
(Figure 3.4). Cell spreading is a measure of the surface area of actin normal-
ized for the number of cells, and is a measure of the strength of cell adhesion.
More information for these calculations may be found in the Appendix. For
each sample type, six samples were taken (n = 6). Plain samples refer to pure
76
Figure 3.4: Cell spreading, or the actin surface area covered per cell, for B16
cancer cells seeded on: 1) plain nonmodified PLLA films; 2) films modified
to express n-cadherin using amine-amine coupling; and 3) films modified to
express n-cadhering using amine-carboxyl binding. Cell spreading is an indi-
cator of the extent of cellular adhesion strength. Values are given as the mean
± standard error of the mean (n = 3). Statistical significance compared to
controls is indicated by ∗ (p < 0.01).
PLLA scaffolds. Negative control refers to the amine-amine reaction scheme
discussed previously. This scheme produced reduced cell adhesion, despite
being expected to express the n-cadherin moeity, due to the orientation of n-
cadherin which blocks the binding sites the cells utilize. The amine-carboxyl
scheme exhibited significatly improved cell adhesion, well over two times com-
pared to non-functionalized scaffolds.
3.3.3 Seeding Efficiency
Figure 3.5 compares the seeding efficiency of cells seeded on non-modified
and carboxyl modified scaffolds. Also listed as a comparison are the seeding
efficiences for MSCs. It is clear that cancer cells have a highly reduced at-
tachement rate to unmodified PLLA scaffolds, ranging from 5-12%. With this
in mind, it is a positive finding that B16 cells seeded on modified scaffolds
77
Figure 3.5: Seeding efficiency of various cell types on PLLA scaffolds. (Mod)
indicates cells were seeded on scaffolds that have been modified to express
RGD using amine-amine coupling (MSCs) or n-cadherin using amine-carboxyl
binding (B16). Values are given as the mean ± standard error of the mean (n
= 3). Significance is indicated by ∗ (p < 0.01), and was calculated via ANOVA
with Tukey HSD Post-hoc analysis.
have a seeding efficiency comparable to MSCs on nonmodified scaffolds.
3.4 Discussion
The goal of this study was to compare the seeding efficiency of cancer cells
on normal PLLA polymer scaffolds and n-cadherin expressing PLLA scaffolds.
Initially, a variety of cells, both MSCs and cancer, were seeded on unmodified
and modified 2D PLLA films. The goal of this was to gain a measure of the
cell density and cell spreading on the different surfaces. After seeding, cells
were fixed, stained, and imaged by fluorescent microscopy. Figure 3.3 shows
a pronounced difference in B16 cell density on unmodified and modified films.
Modified films show a large amount of cells adhered to the surface of the
film and elevated actin stretching, while there are a minimal amount of cells
adhered to the unmodified films and minimal actin stretching.
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Figure 3.4 quantifies the difference in cellular adhesion on unmodified and
modified surfaces. After generating the fluorescent images, surfaces were eval-
uated for the actin surface area per cell. This value gives a look into the
strength of cell binding to the surface, as stronger adhesion will manifest from
actin stretching out to attach to a larger surface area. As seen in the graph,
cell spreading on the films modified using the amine-carboxyl modification
scheme, producing stretching three times the amount of the plain and amine-
amine scheme. Additionally, the amine-amine scheme functions as a negative
control, as that modification process blocks binding site, preventing cells from
adhering. The error present in the plain films highlights the variability exh-
bited when seeding cancer cells on polymer scaffolds.
Finally, the seeding efficiency for MSCs and cancer cells on both unmodified
and modified 3D scaffolds. MSCs were seeded on RGD expressing scaffolds,
which we investigated in a previous study. As seen in Figure 3.5, MSCs have a
30% higher adhesion rate to RGD modified scaffolds (∼55%) than plain scaf-
folds (∼25%). When comparing that result to the adhesion rates of cancer
cells, it is evident that there is a large disagreement between the two. Initial
seeding efficiencies on plain PLLA scaffolds for PC3s, MDAs, and B16s are
about 15% lower than MSCs. MDAs exhibit the lowest adhesion rates, with
less than 10% of the intial cells seeded on the scaffolds remaining after incu-
bation. Not only is this a significant detriment in terms of the time required
to culture dense tumor in vitro, but it also means that an overwhelming ma-
jority of cancer cells used for 3D in vitro culture will be wasted. Importantly,
when seeded on n-cadherin expressing scaffolds, the abysmal seeding effiency
of B16s is increased to a comparable rate of MSCs on non-modified scaffolds,
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over twice the intial rate. Clearly, the modification scheme presented in this
manuscript provides the means to gain workable cancer cell adhesion rates on
PLLA scaffolds.
3.5 Conclusion
In this study we sought to leverage our surface modification platform for in
vitro tumor engineering. In particular, we aimed at increasing cancer cell ad-
hesion rates to poylmer scaffolds. We improved upon past work by modifying
scaffolds with n-cadherin, peptide that has been show to mediate cell-to-cell
adhesion in metastatic tumors. Following modification, we seeded scaffolds
with a variety of cell lines, such as PC3 prostate cancer, MDA breast cancer,
and B16 melanoma. Through fluorescent imaging and biochemical assays, we
able to validate our hypothesis. Imaging highlighted the disparity in cell ad-
hesion on modified and unmodified scaffolds, with B16s showing elevated cell
density in the n-cadherin expressing surfaces. This result was quantified by
measuring the cellular spreading on those same groups. Again cells seeded on
n-cadherin expressing surfaces displayed elevated levels of adhesion. Lastly, we
measured the seeding efficiency of cancer cells on the two groups and compared
the results with those from MSCs. By modifying the scaffolds, we were able
to increase B16 seeding to rates comparable to MSCs on non modified scaf-
folds. These findings support the use of our modification scheme to increase
the viability of in vitro tumor engineered constructs.
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Chapter 4
On the Effects of 3D Printed
Scaffold Architectures on
Flow-Induced Shear Stress
Distributions
Abstract
As 3D printing gains more exposure as the future of scaffold fabrication for
tissue engineering, the ability to preemptively model the constructs microenvi-
ronment becomes of vital importance. Particularly when using perfusion based
bioreactor systems for bone tissue engineering applications, the most impor-
tant properties to obtain are the fluid flow and wall shear fields that potential
cells will experience during and after seeding. Traditionally, 3D printing has
given users the impression that the scaffold obtained after printing will exhibit
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the same, or closely similar, architecture as the designed model. While this
may be the case in terms of the macrostructure, we hypothesized that the local
fluid dynamic environment would differ greatly. The intention of this study
was to 3D print scaffolds of various pore size gradients, image these constructs
utilizing micro-computed tomography, and perform computational fluid dy-
namic simulations on the resulting reconstructions and the initial designs in
order to compare the average shear on the fibers, where the cells would be
adhered. As a determining factor, the probability density function (p.d.f.) of
each was compared to not only highlight the major differences, but also to
show the reproducibility of the printing process. The results presented in this
manuscript give users the knowledge of how the 3D printing process may alter
the intended fluid environment they designed, and how to, in spite of that fact,
produce repeatable results.
4.1 Introduction
Tissue engineering seeks to repair tissue damage associated with acute trauma
or surgery [14]. Bone tissue engineering in particular aims to alleviate the
problems of low graft supply and donor site morbidity, commonly attributed
to autologous bone transplants from one region of the body to another. A
simple approach consists of harvesting patient stem cells, seeding them on
three dimensional scaffolds, and culturing them in a bioreactor. Once prop-
erly developed, the tissue matrix is reinserted at the location requiring tissue
This study was completed thanks to the collaborations listed in the acknowledgments.
Listed here are the author contributions: CW performed image analysis; performed recon-
structions and flow simulations; performed data analysis; and wrote the manuscript. GM
performed microcomputed tomography imaging. JET and MS performed scaffold charac-
terization. CMP fabricated scaffolds.
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repair, providing both material to provide support and cells optimized to mend
the damaged tissue. By developing in vitro tissue culture techniques, tissue
engineered bone will one day be able to be used during graft surgeries. For
this proposed therapy to work, however, it is of utmost importance to produce
consistent grafts during every culture.
For engineered bone, both the choice of scaffold used to support cells in
culture and the bioreactor used to provide mechanical stimulation play signif-
icant roles in cell viability and ex vivo tissue development. Scaffold proper-
ties, such as pore size and porosity, must be manipulated to match desirable
tissue properties. In order to bring up repeatable scaffolding conditions in
every culture, 3D printing has emerged as the premier fabrication method
for tissue engineering [7, 18, 6, 19]. It allows for the reproducible manufac-
turing of scaffolds with near limitless geometries. Additionally, a wide range
of materials may be used during production, such as synthetic polymers like
poly(l-lactic acid) and poly(propylene fumarate) or natural materials such as
collagen or silk. Poly(propylene fumarate) (PPF) is a widely used material
for bone tissue engineering due to its compatibility with the osteoblastic cells
[8, 1, 5, 7, 10, 11, 12], mechanical properties [13, 23], and its compatibility with
extrusion-based 3D printing [9]. In addition to providing a suitable material
for bone tissue engineering, the combination of this polymer with extrusion-
based printing has enabled the fabrication of scaffolds with controlled pore
sizes. The ability to regulate the pore size within each layer of a scaffold will
allow researchers to tailor scaffold geometries to give the most beneficial flow
environment [9, 18].
Previous studies combining flow perfusion experiments with computational
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fluid dynamic simulations have shown that shear stresses below 15 dynes/cm2
are conducive to increased matrix production and osteoblastic differentiation.
Additionally, elevated shear stresses may cause increased cell detachment. Due
to this, it is important to properly model and evaluate the flow profile inside
cell-seeded scaffolds. Ideally, the localized shear rates would be anticipated
in order to give proper fluid control. To this end, 3D printing has been in-
vestigated as a method to fabricate reproducible architectures, and, in turn,
reproducible flow fields.
In this study, we have utilized extrusion based 3D printing to fabricate
scaffolds that exhibit varying pore sizes and/or varying pore size gradients.
These varying conditions were chosen in an attempt to control the shear envi-
ronments experienced by cells under flow perfusion. The resulting constructs
were imaged utilizing µCT, segmented, and reconstructed following previously
published techniques [21, 22, 16]. This flowpath allows for subsequent compu-
tational fluid dynamic (CFD) simulations on the printed scaffolds that may
then be compared to the initial designs.
In this manuscript, we hypothesized that the levels of fluid shear present at
the walls of a 3D printed scaffold will vary greatly from the anticipated shear
on the designed computer aided design (CAD) file (in the STL file format).
In particular, it is not a valid assumption that 1) the shear field predicted
in the CAD design will directly translate to the printed scaffold and 2) that
the probability density functions (p.d.f.) will be fully described by the same
relationships. The intention of this study is to use CFD simulations to ex-
pose the aforementioned differences and bring to light relationships between
CAD designs and the resulting reconstructions, which would give researchers
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Figure 4.1: Cross-sectional view of gradient scaffold orientations with the fol-
lowing pore sizes: large (L) = 1 mm, medium (M) = 0.6 mm, small (S) = 0.2
mm. Image taken from previous publication [19].
the ability to anticipate the flow environment within a construct before the
printing process.
4.2 Materials & Methods
4.2.1 Scaffold Design
PPF (Mn, 2280 ± 23 Da; PDI, 1.72 ± 0.02) scaffolds were fabricated by stack-
ing individual 3D printed layers of large (L), medium (M), or small (S) pore
sizes, Figure 4.1, using a step-growth polymerization reaction [5, 8, 1]. The
PPF printing solution was prepared using protocols described in a previous
study [18]. Briefly, PPF was mixed with diethyl fumarate (DEF, Sigma, St.
Louis, MO) in an 85:15 wt% ratio. First, a photoinitiator, phenylbis(2,4,6-
trimethylbenzoyl)-phosphine oxide (BAPO, BASF, Florham Park, NJ), was
dissolved in DEF (with 1 wt% BAPO) by vortexing and was mixed with warm
PPF (∼70 oC) to permit UV crosslinking.
Layers of dimensions 10x10x0.54mm were drawn (SolidWorks, Waltham,
MA), sliced (Bioplotter RP, EnvisionTEC, Gladbeck, Germany), and printed
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at the following conditions: extruder temperature (55 oC), platform tempera-
ture (5 oC), print head speed (5 mm/s), needle offset (0.25 mm), and syringe
tip diameter (0.34 mm). Pore sizes ranged from 0.2 mm (small, S), 0.6 mm
(medium, M), and 1 mm (large, L). Following printing, printed layers under-
went UV crosslinking (single projection, 10s exposure, 70 mm height) following
established methods [18]. Fiber diameter and pore sizes were validated follow-
ing stereomicrscopy imaging (MZ6, Leica Microsystems, Wetzlar, Germany)
(n = 12 scaffolds per group, 5 measurements per image) (ImageJ, NIH).
4.2.2 Porosity Measurements
Porosity was quantified (n = 12 per group) using gravimetric analysis following
previous methods [[17, 3, 20]. Briefly, sample dimensions (length, L; width,
W; thickness, T) and weight w material were measured and used to calculate
the porosity according to Equation 1, where ρscaffold is the scaffold density and
ρmaterial is the density of the material. The respective densities of PPF (1.267
g/mL) [16], DEF (1.052 g/mL) (Sigma), and BAPO (1.19 g/mL) (BASF) were
used to estimate ρmaterial.
 = 1− ρscaffold
ρmaterial
= 1− wscaffold
LWTρmaterial
(4.1)
4.2.3 Cell Expansion, Seeding, and Culture
The human Ewing sarcoma (ES) TC71 cells (MD Anderson Medical Center)
were cultured in Roswell Park Memorial Institute (RPMI) medium 1640 (Medi-
atech) supplemented with 10% FBS (Gemini) and antibiotics/antimycotic (100
IU/mL penicillin and 100 µg/mL streptomycin; Gibco) until reaching 85% con-
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fluency. RPMI medium 1640 was supplemented with 10% FBS (Gemini Bio-
products) and antibiotics (100 IU/mL penicillin and 100 µg/mL streptomycin;
Gibco). After reaching confluency, cells were lifted with 0.05% trypsin-EDTA
(Gibco), and counted with a hemocytometer.
3D printed scaffolds were sterilized in a 24 hour ethylene oxide cycle (An-
derson Sterilizers) and allowed to de-gas for 12 hours prior to cell culture.
Scaffolds were pre-wet in 75% ethanol using the methods described in previous
publications[2]. In an attempt to increase cell attachment, pre-wet scaffolds
were incubated on a rotating shaker overnight in 1 mL complete medium.
Each scaffold was seeded with 200,000 cells/mL RPMI and allowed to adhere,
overnight, on a rotating table in an incubator. Constructs were cultured for
up to 16 days at a flowrate of 0.1 mL/min.
4.2.4 Imaging and Reconstruction
The scaffolds were scanned non-destructively with micro-computed tomogra-
phy (µCT) using a commercial system to obtain 2D image slices (Quantum FX,
Perkin Elmer, Waltham, MA; L10101, Hamamatsu Photonics, Japan; PaxS-
can 1313, Varian Medical Systems, Palo Alto, CA). The images were then
filtered, thresholded, and stacked using the open-source visualization software
3D Slicer (slicer.org) to form the 3D reconstructions. Before concluding each
reconstruction, the porosity was measured and matched to that of the printed
scaffold in order to assure a proper segmentation. This method has proven
successful for previous studies [21, 22, 16] For each scaffold, slices were cut
off from the edges of the reconstruction to avoid end effects in the computa-
tional fluid dynamic (CFD) simulations. The exact size of the resulting digital
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scaffold was different for each case; however, the typical size for each recon-
struction was approximately 10 x 10 x 1.2 mm (length x width x height). For
this study, we investigated a total of 12 different sets of reconstructions.
4.2.5 Computational Simulations
Simulations were performed using Fluent 16.2 (ANSYS, Inc.), which has been
extensively utilized for computed surface shear stresses on µCT reconstructions
[21, 22, 16, 15]. A simulation domain was implemented that cooresponded to
the bioreactor cassette of the length and width specified in the previous section.
Fluid flow conducted with flat velocity profiles at the inlets based on a flow
rate of 0.1 mL/min, no-slip boundary conditions imposed at the walls of the
domain, and also an outlet with constant static pressure [16]. The culture
medium was modeled as an incompressible Newtonian fluid with a dynamic
viscosity of 1 cP, according to previous studies [21, 16]. In order to avoid
any unwanted entrance effects and allow for fully developed laminar flow, we
added a 4.8 mm long inlet channel in front of the scaffolds, which satisfies the
conditions for laminar flow in a non-circular pipe [4]. Hydraulic radius (Dh),
cross-sectional area (A), perimeter of the channel (m2), Reynolds number (Re),
average velocity (v), medium density (ρ), medium viscosity (µ), and entrance
length (EL) and are defined in Equation 2-Equation 4:
Dh =
4A
P
= 10mm (4.2)
Re =
2Dh〈v〉ρ
µ
<< 1 (4.3)
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EL = 0.035ReDh << 4.8mm (4.4)
Scaffolds were meshed using approximately 950,000 grid cells with a size of
7 µm. Polyhedral element geometries were used for the scaffolds themselves,
while tetrahedrals were used on the domain walls and the exit side of the scaf-
fold to minimize computational time. The goal of this study is to evaluate the
shear at the fluid-scaffold wall interface, therefore only wall shear values at
these surface nodes were included in calculations. Additionally, shear distri-
butions were plotted using 1,000 equally sized bins. It must be noted that wall
shear stress as indicated in this chapter includes both the shear and normal
stress on the walls of the scaffold.
4.2.6 Probability Density Functions
In a previous study [22], it was found that the normalized flow induced shear
stresses in highly porous nonwoven fiber mesh scaffolds (85% and above) follow
a three-point gamma distribution, Γ(2.91, -1.43, 0.45), defined in Equation 5-6:
f(τ ∗w) =
(τ ∗w − γ)α−1
βαΓ(α)
exp
{−(τ ∗w − γ)
β
}
(4.5)
τ ∗w =
τw − τ¯w
σ
(4.6)
where α = shape, β = scale, and γ = location. Additionally, the work
was expanded to describe other scaffold types when only τ is known by using
a standard gamma distribution (γ = 0) with parameters α = 2.91 and β =
0.315τw [15]. Furthermore, this study was followed by another manuscript
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which validated this distribution for structured scaffolds. All p.d.f.s where
fit and plotted using a custom python code utilizing the open source Numpy,
matplotlib, and SciPy libraries.
4.2.7 Statistical Analysis
A one-way analysis of variance (ANOVA) was used to compare mean ± stan-
dard deviation of pore and fiber measurements, in which Tukeys Honestly Sig-
nificant Difference (HSD) test was performed to identify significant differences
(p-value < 0.05). One-way ANOVA and Tukeys HSD were used to 1) compare
top, middle, and bottom layers within each gradient orientation (LMS, MMM,
SML) and 2) compare all top (middle, and bottom) layers across gradient ori-
entations. In order to compare results within specific scaffold layers across
culture conditions (eg. LMS = top layer under static vs flow perfusion), pair-
wise comparisons were made using Students t-test (p < 0.05). All statistical
analysis was performed using a custom python code utilizing the open source
Numpy, matplotlib, and SciPy libraries.
4.3 Results
4.3.1 Shear Stress Distributions per Scaffold Layer
We compared the magnitude of the wall shear stress in each layer of the 3D
printed PPF scaffolds (Figure 4.2) for both the stereolithography (STL) CAD
models of the scaffolds (generated to communicate the scaffold pattern to the
3D printer) and the 3D printed scaffolds, which were analyzed via µCT to
generate a 3D reconstruction. For a flow rate of 0.6 mL/min, we observed
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Figure 4.2: Summary of average shear stress for 0.1 mL/min flow rate, com-
paring computer aided design (CAD) model to scaffold (µCT reconstruction).
FLUENT simulations were run either on the reconstructed scaffold or the orig-
inal CAD model used to print said scaffolds. Values are given as the mean ±
standard error of the mean (n = 4).
a dramatic difference in magnitude between the STL files and the µCT re-
constructions (an increase by a factor of 10-100 for all groups). The shear
stress magnitude in the gradient configurations (SML, LMS) appeared to be
greater than in the uniform scaffold configuration (MMM). Supplemental Fig-
ures 4.10 - 4.12 represent computational models of average wall shear stress
within the STL file layers and scaffold layers for respective SML, MMM, and
LMS configurations.
4.3.2 Shear Stress Distributions per Construct
Additionally, we compared the average overall shear stress in each of the scaf-
fold types, MMM, SML, and LMS for both STL models and the reconstruc-
tions. As shown in Figure 4.3, it is clear that there is a pronounced difference
between the shear values seen in the models versus the printed scaffolds. This
result is supported in Figure 4.4, which shows the wall shear distributions per
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Figure 4.3: Summary of average shear stress per layer for 0.1 mL/min flow rate,
comparing LMS, SML, and MMM scaffold architecture (µCT reconstructions).
Pore sizes ranged from 0.2 mm (small, S), 0.6 mm (medium, M), and 1 mm
(large, L). Values are given as the mean ± standard error of the mean (n =
4).
construct on reconstructed scaffolds and CAD designs. For a given number
of node points on the walls of the scaffolds, these graphs give the number of
times (frequency) a certain shear stress value is expressed. In terms of the re-
constructions, scaffolds that contain the same porosity seem to experience the
same average shear stress, which is consistent with previous findings. Figure
4.5 shows the distributions in the top layer for each gradient orientation.
4.3.3 Effects of Printing Defects on Shear Stress Levels
Figures 4.6 and 4.7 show lateral sections of reconstructed scaffold, with wall
shear stress overlaid on top. It is evident that there are high levels of shear
stress are located around defects created during the 3D printing process, as
indicated by the black arrow. Additionally, Figure 4.8 shows an SEM micro-
grapgh of cells seeded on the same construct. These cells are present in the
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Figure 4.4: Wall shear stress distributions [cPa] based on gradient orientation
(LMS, MMM, and SML) and scaffold type (reconstruction or CAD). Pore
sizes ranged from 0.2 mm (small, S), 0.6 mm (medium, M), and 1 mm (large,
L). FLUENT simulations were run either on the reconstructed scaffold or the
original CAD model used to print said scaffolds.
Figure 4.5: Wall shear stress distributions [cPa] based on gradient orientation
(LMS, MMM, and SML) for reconstructions. The left image compares the
distributions for the entire scaffolds, whereas the right image compares the
disributions in the top layers.
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Figure 4.6: Top view of 3D printed scaffold layers. Average wall shear stress
per layer (top, middle, and bottom) for all gradient orientations (LMS, MMM,
and SML). Wall shear stress is mapped as a color distribution (heat map) on
the top surface of each layer.
interior of the scaffold, cooresponding to the areas of low shear in the previous
figure.
4.3.4 Probability Density Function
Figure 4.9 also displays the probability density functions for the various scaf-
fold subsets along with the standard gamma distribution fit. Indeed, the recon-
structions all display close agreement to the fit, within statistically acceptable
bounds.
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Figure 4.7: Top view of scaffold layer. Wall shear stress is mapped as a color
distribution (heat map) on the top surface of each layer. Heat map indicates
distribution of high (red, 8 cPa) to low (blue, 0 cPa) shear stresses. Heat
map legend applies to all layers. Black arrows are indicating defects. Defects
can manifest as uneven printed layers, fibers that have joined together, or
clogged/misshapen pores.
Figure 4.8: Top view of SEM micrograph of scaffold layer. Cells are aggregated
in the interior of the scaffold consistent with area of low fluid shear stress
indicated in Figure 4.7.
97
Figure 4.9: Probability density functions for each gradient scaffold (LMS,
SML, and MMM) and the standard gamma distribution. P.D.F. for the LMS
gradient scaffold is shown; however, very closely matched by that of the SML
gradient scaffold.
4.4 Discussion
After generating shear stress profiles under several flow rates (up to 6 mL/min
tested), the flow rate was adjusted to 0.6 mL/min to achieve physiologically
relevant shear stresses within scaffold layers based on previous work [7]. We
compared the average wall shear stress in each layer of the 3D printed PPF
scaffolds (Figure 4.2), which were scanned via µCT to generate a 3D recon-
struction. Computational modeling indicated that the average shear stress was
higher in the top layer compared to the middle and bottom layers for both
the SML and MMM orientations, while no statistical significance was found
among layers in the LMS configuration. This study was also performed on
the CAD designs of the scaffolds. Once again, the highest shear stress levels
were found at the top layer of the scaffolds towards the flow inlet. We believe
this difference is due to the smaller sized pores at the top of the MMM and
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SML scaffolds, whereas the LMS scaffolds have large pore diameters at the
top, offering less resistance to inlet flow.
When comparing the results between the reconstructions and CAD designs,
it is evident that there is a large disagreement between the two. Not only is
significant difference in the overall average shear stress found in the two types,
but there are also differences in the radial directions. Particularly, the shear
fields found in the CAD designs are consistent from the interior of a layer
out to the periphery, whereas the shear fields found in the reconstructions to
not express this same characteristic. This is compounded by the high shear
stress values found localized around defects in the printed scaffolds, as shown
in Figure 4.7. Clearly, these defects have a significant part in altering the
flow environment within the constructs resulting in flow being preferential
distributed to areas of low resistance. Furthermore, we believe the differences
observed may also be due to the surface roughness of the printed scaffolds due
to the fact that a CAD design has a smoothness that cannot be replicated in
a printed scaffold without significant post-processing. Additionally, previous
studies have shown that a smooth surface on a scaffold is not preferable for
cellular adhesion; therefore, in terms of scaffolds for cell and tissue growth,
there will always be this disparity. Also of note, cells were imaged in loocations
that coorespond to areas of low fluid shear, approximately below 3 dynes/cm2.
On a per construct basis, the average wall shear stresses were compared.
Consistent with previous findings for randomly oriented scaffolds, we found
that constructs having the same porosities will display not only the same
average shear values, but will also have the same distribution of shear induced
stress on the construct as a whole. This phenomenon holds true for both the
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CAD designs and the reconstructions, as LMS and SML orientations presented
statistically identical shear distributions.
Finally, the probability density functions were compared for all groups.
A standard gamma distribution fit, Γ(2.91,0,0.315), was found that describes
the results for all of the reconstructions and is within statistically acceptable
bounds [22, 15]. As we hypothesized, this distribution is not statistically
acceptable for describing the CAD designs. In other words, the differences
found between the reconstructions and the idealized designs are not simply
three orders of magnitude apart, but exhibit wildly different fluid environments
that cannot be easily dismissed or predicted. This means it is necessary to run
fluid dynamic simulations on the actual printed scaffolds in order to obtain
any insight into both the viability of a design and the environment the cells
will experience.
4.5 Conclusion
In the presented manuscript, we hypothesized that the levels of fluid shear
present at the walls of a 3D printed scaffold will vary greatly from the antici-
pated shear on the designed CAD file. In order to accomplish this, 3D printing
was used to fabricate scaffolds that exhibited varying pore sizes and/or pore
size gradients. These constructs were then imaged using µCT and recon-
structed to allow for CFD simulations to be performed. Average shear stress
values, both per layer and per construct, were compared, and confirmed major
differences between the idealized model and reconstructions.
An important finding was that when the orientation consists of large pores
at the inlet leading to the pores, the average shear stress is consitent through-
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out the scaffold due to the fluid being funneled into the next layer. The
opposite is found with the small to large orientations, where the fluid experi-
ences the largest magnitude at the inlet. In a few instances, localized regions
of higher shear stress were observed near the edges (eg. SML top layer) and
near defects within the 3D printed scaffolds (eg. MMM middle layer). To
accompany these findings, p.d.f.s of the wall shear stress for the resulting re-
constructions and the initial designs were compared, highlighting confirming
the disparities between the two. Finally, we proved that a previously identified
standard gamma distribution describes the p.d.f. of flow induced stresses in
the reconstructions. Statistically, however, this distribution does not describe
those of the CAD designs within acceptable limits. In conclusion, researchers
should never rely on intuition alone, due to the complexity of the fluid-scaffold
interactions, and computational modeling should be utilized whenever possi-
ble.
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Supplemental Figures
Figure 4.10: Wall shear stress (Pa) for SML a) STL files and b) µCT recon-
structions at low flow rate (0.1 mL/min). Yellow arrows indicate the direction
of flow. Simulations were conducted using FLUENT run either on the recon-
structed scaffold or the original CAD model used to print said scaffolds.
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Figure 4.11: Wall shear stress (Pa) for LMS a) STL files and b) µCT recon-
structions at low flow rate (0.1 mL/min). Yellow arrows indicate the direction
of flow. Simulations were conducted using FLUENT run either on the recon-
structed scaffold or the original CAD model used to print said scaffolds.
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Figure 4.13: Wall shear stress distributions [cPa] based on gradient orientation
(LMS, MMM, and SML) and scaffold type (CAD). Simulations were conducted
using FLUENT run either on the reconstructed scaffold or the original CAD
model used to print said scaffolds
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Chapter 5
Time-Dependent Shear Stress
Distributions during Extended
Flow Perfusion Culture of Bone
Tissue Engineering Constructs
Abstract
Flow perfusion bioreactors have been extensively investigated as a promising
culture method for bone tissue engineering, due to improved nutrient deliv-
ery and shear force mediated osteoblastic differentiation. However, a major
drawback impeding the transition to clinical relevant tissue regeneration is
the inability to non-destructively monitor constructs during culture. To alle-
viate this shortcoming, we investigated the distribution of fluid shear forces
in scaffolds cultured in flow perfusion bioreactors using computational fluid
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dynamic techniques, analyzed the effects of scaffold architecture and surface
chemistry on the shear forces, and monitored tissue mineralization through-
out the culture period using micro-computed tomography. For this study, we
dynamically seeded one million adult rat mesenchymal stem cells (MSCs) on
85% porous poly(L-lactic acid) (PLLA) polymeric spunbonded scaffolds. After
taking intermittent sammples over 16 days, the constructs were imaged and
reconstructed using micro-computed tomography. Fluid dynamic simulations
were performed using FLUENT and a custom in-house lattice Boltzmann pro-
gram. By taking samples at different time points during culture, we are able
to monitor the mineralization and resulting changes in flow-induced shear dis-
tributions in the porous scaffolds as the constructs mature into bone tissue
engineered constructs, and subsequently predict a constructs future growth.
5.1 Introduction
Every year in the United States, there are more than 500,000 bone graft surg-
eries [11]. In most cases, bone will regenerate after fracture with minimal
complications; however, when there is a critical-sized defect or fracture heal-
ing is impaired, bone grafts must be used in order to regain proper bone
function. Furthermore, bone diseases such as osteoporosis, infection, skeletal
defects, and bone cancer may also cause a need for bone grafts. Bone tissue en-
gineering is a possible solution to the problems plaguing the current bone graft
therapies. Because tissue engineered bone would be made using the patients
This study was completed thanks to the collaborations listed in the acknowledgments.
Listed here are the author contributions: CW performed cell culture; bioreactor experiments;
image analysis; performed reconstructions and FLUENT flow simulations; performed data
analysis. OEK performed LBM simulations; developed Figure 5.7 and 5.8b. GM performed
microcomputed tomography imaging.
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own cells, immune rejection would be eliminated. For this to work, four com-
ponents are needed for tissue growth: cells that can be differentiated into bone
cells, osteoconductive scaffolds for acting as a matrix while the tissue grows,
growth factors and other chemical stimulation, and mechanical stimulation to
encourage osteogenic differentiation. Mechanical stimulation, in particular, is
implemented through the use of bioreactors.
Previous studies have given the indication that the shear stress cells ex-
perience inside the body are between 8-30 dynes/cm2 [13]. In vitro culture
studies combined with computational fluid dynamic simulation results have
shown that shear stresses below 15 dynes/cm2 are conducive to increased ma-
trix production and osteoblastic differentiation. However, if the shear rates
are too high, detachment or cell death can occur. Due to this, it is important
to properly model and evaluate the flow profile inside cell-seeded scaffolds.
Ideally, the localized shear rates would be anticipated in order to give proper
fluid control. However, the largest barrier to this goal is the continual de-
position of mineralized tissue during the culture period. After the stem cells
differentiate into mature osteoblasts, both soft and hard extracellular matrix
grow into the pores of the construct. This effectively alters the flow field, due
to the porosity of the scaffold decreasing, and renders simulations performed
on empty scaffolds invalid after the start of culture.
To combat this issue, we aimed to evaluate the localized fluid shear distri-
butions throughout the culture period. Using spunbonded poly(l-lactic acid)
scaffolds and a custom flow perfusion bioreactor, we cultured rat mesenchymal
stem cells for 16 days under shear induced differentiation flow ranges. The re-
sulting constructs were imaged utilizing µCT, segmented, and reconstructed
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Figure 5.1: Common sythentic polymeric scaffolds used for tissue engineering.
Scaffolds manufactured using spunbonding and imaged using SEM.
following previously published techniques [13, 8]. This flowpath allows for
subsequent computational fluid dynamic (CFD) simulations on the cultured
constructs.
In this manuscript, we hypothesized that the levels of fluid shear present at
the walls of a scaffold, where the cells are located, will increase as a function of
culture time. Previous studies have assumed that 1) the shear field predicted
using a non-cultured scaffold is representative for cultured constructs and 2)
that the average wall shear experienced by the cells is constant throughout a
culture period [9, 5]. The intention of this study is to use CFD simulations in
conjunction with microcomputed tomography of mature constructs and bio-
chemical assays to bring to light the relationship between the localized shear
field and culture time, which would give researchers the ability to predict the
time dependant shear distribution in conjuction with the growing extracellular
matrix within three dimensional scaffolds exposed to flow perfusion.
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Figure 5.2: Schematic of custom in-house perfusion bioreactor system. The
right image shows the combination of bioreactor body, scaffold cassettes, and
stand.
5.2 Materials & Methods
5.2.1 Scaffold Manufacturing
Poly(L-lactic acid) (PLLA; grade 6251D; 1.4% D enantiomer; 108,500 MW;
1.87 PDI; NatureWorks LLC) nonwoven fiber mesh scaffolds were produced
via spunbonding, as previously indicated from previous studies [12]. Scaffolds
were cut from an 8mm thick PLLA mat, resulting in scaffolds of 88% porosity.
A Nikon HFX-II microscope was used to evaluate fiber diameter, found to be
24.5 µm, and was confirmed by scanning electron microscopy, shown in Figure
5.1.
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5.2.2 Cell Expansion, Seeding, and Culture
Adult mesenchymal stem cells were extracted from the tibias and femurs of
male Wistar rats (Harlan Laboratories) using methods identified in previous
publications [11, 1]). Cells were cultured at 37 oC, and 5% CO2 in standard
α-MEM (Invitrogen) supplemented with 10% fetal bovine serum (Atlanta Bio-
logicals) and 1% antibiotic-antimycotic (Invitrogen). Passage 2 cells were used
for this study at a density of 2 million cells/mL for scaffold seeding.
We prepped the scaffolds for cell seeding using an established pre-wetting
technique [2]. Vacuum air removal of scaffolds was conducted in 75% ethanol.
Pre-wet scaffolds were placed in cassettes within a flow perfusion bioreactor
for a one hour in α-MEM to remove any remaining ethanol [6, 3]. Schematics
of the perfusion system used for this study may be found in Figure 5.2. Fol-
lowing the flush, 2 million MSCs/150 µL of osteogenic α-MEM were pipetted
in each each scaffold chamber. The seeding mixture was dynamically per-
fused at 0.15 mL/min, forwards and backwards, in five minute intervals for
two hours. Osteogenic media consists of standard α-mem supplemented with
dexamethasone, beta-glycerophosphate, and ascorbic acid, which have been
shown to induce osteogenic differentiation [10]. After oscillatory seeding, the
bioreactor was allowed to rest for two hours, without flow, to facilitate cell
attachment. Finally, osteogenic α-MEM was continuously perfused at a rate
of 0.5 mL/min/scaffold for the remainder of the culture period of 1, 4, 8, 11,
and 16 days.
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5.2.3 Construct Cellularity
The number of cells present in each construct was evaluated using fluorescent
PicoGreen dsDNA assay (Invitrogen). At each sacrificial time point, the con-
struct was removed from the cassette and dunked in PBS to remove any cells
not adhered to the scaffold. Subsequently, the scaffolds were chopped into
eight pieces, placed in 1 mL of DI H2O, and stored at -20
oC. Each construct
underwent three freeze/thaw cycles to lyse the cells. After following supplier
protocols, solutions were run on a Synergy HT Multi-Mode Microplate Reader
(Bio-Tek) at an excitation wavelength of 480 nm and an emission wavelength
of 520 nm. All samples and standards were run in triplicate. Resulting values
were then divided by the previously determined dsDNA content per cell of
rMSCs which follows the equation below:
m dsDNA
cell
(pg) = 4.5− 0.0102 ∗ t2 (5.1)
,where t = culture time, which quantifies the loss of dsDNA content per
cell as MSCs differentiate towards osteoblastic maturity.
5.2.4 Construct Calcium Deposition
Calcium deposition was measured utilizing the cellular lysate aquired following
the freeze/thaw cycles of the previous section. The solution was measured with
a calcium colorimetric assay using the manufacturer protocol (Sigma, Cat. #
MAK022). Samples were again read on a Synergy HT Multi-Mode Microplate
Reader (Bio-Tek) at an absorbance of 575 nm. All samples and standards were
run in triplicate.
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5.2.5 Imaging and Reconstruction
Micro-computed tomography was used to non-destructively scan the scaffolds
(Quantum FX, Perkin Elmer, Waltham, MA; L10101, Hamamatsu Photonics,
Japan; PaxScan 1313, Varian Medical Systems, Palo Alto, CA). The result-
ing 2D image slices were filtered, thresholded, and stacked using the open-
source visualization software 3D Slicer (slicer.org). Following reconstruction,
the porosity of the digital scaffold was measured and compared to the actual
spunbonded scaffolds in order to assure a proper segmentation. This method
has proven successful for previous studies [14]. For this study, we investigated
a total of 4 different scaffolds for each day of construct sacrifice.
5.2.6 CFD Simulations
Simulations were performed via multiple methods to ensure the accuracy of
the results - Finite Volume method implemented in Fluent 16.2 (ANSYS, Inc.)
and Lattice-Boltzmann method implemented using a custom in-house Lattice-
Boltzmann code, both of which have been extensively utilized for computing
surface shear stresses on µCT reconstructions [13, 14, 8, 7]. Lattice Boltzmann
simulations were conducted by our collaborators.
Fluent Simulations
Fluent simulations were conducted similarly to the previous chapter, with flat
velocity profiles at the inlets based on a flow rate of 0.1 mL/min, no-slip
boundary conditions imposed at the walls of the domain, and also an outlet
with constant static pressure [8]. The domain for this study was a circular
pipe with a diameter of about 5.5 mm. This cooresponds to the size of the
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cassettes used in the bioreactors during culture. The culture medium was
modeled as an incompressible Newtonian fluid with a dynamic viscosity of
1 cP, according to previous studies [13, 8]. In order to avoid any unwanted
entrance effects and allow for fully developed laminar flow, we added a 4.8
mm long inlet channel in front of the scaffolds, which satisfies the conditions
for laminar flow in a pipe [4]. Hydraulic radius (Dh), cross-sectional area (A),
perimeter of the channel (m2), Reynolds number (Re), average velocity (v),
medium density (ρ), medium viscosity (µ), and entrance length (EL) and are
defined in Equation 2-Equation 4:
Dh =
4A
P
= 10mm (5.2)
Re =
2Dh〈v〉ρ
µ
<< 1 (5.3)
EL = 0.035ReDh << 4.8mm (5.4)
Scaffolds were meshed using approximately 5,520,000 grid cells with a size
of 2 µm. Polyhedral element geometries were used for the scaffolds themselves,
while tetrahedrals were used on the domain walls and the exit side of the scaf-
fold to minimize computational time. The goal of this study is to evaluate the
shear at the fluid-scaffold wall interface, therefore only wall shear values at
these surface nodes were included in calculations. Additionally, shear distri-
butions were plotted using 1,000 equally sized bins. It must be noted that wall
shear stress as indicated in this chapter includes both the shear and normal
stress on the walls of the scaffold.
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5.2.7 Statistical Analysis
A one-way analysis of variance (ANOVA) was used to compare mean ± stan-
dard deviation of pore and fiber measurements, in which Tukeys Honestly Sig-
nificant Difference (HSD) test was performed to identify significant differences
(p-value < 0.05). One-way ANOVA and Tukeys HSD were used to the rest of
the results. All statistical analysis was performed using a custom python code
utilizing the open source Numpy, matplotlib, and SciPy libraries.
5.3 Results
5.3.1 Construct Cellularity
In order to validate the presence of cells in the constructs, we conducted a de-
structive dsDNA quantification assay. As shown in Figure 5.3, there is a slight
decrease in scaffold cellularity between Day 1 and Day 4, and a statistically
steady cellularity through the end of culture. The vertical dotted line between
these Day 1 and Day 4 indicates the switch in flow rate from 0.15 mL/min
to 0.5 mL/min. Hence the decrease between these two days represents a loss
of cells due to an increase in shear stress experienced by the cells leading to
detachment. This loss is a common occurence, as MSCs display a low rate of
adherence during the seeding process. The horizontal dashed line represents
the amount of cells initially seeded on the constructs. The ratio between this
line and Day 1 is known as the seeding efficiency, which in this case is 40%.
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Figure 5.3: Construct cellularity for each construct over the culture period.
Horizontal dashed line indicates the initial amount of cells seeded. Vertical
dotted line indicates the switch in flow rates, from 0.15 mL/min during seeding
to 0.5 mL/min for culture. Values are given as the mean ± standard error of
the mean (n = 4).
5.3.2 Calcium Deposition
We followed this by descructively measuring the calcium deposited in each
construct using a calcium assay, with results shown in Figure 5.4. As seen
in the graph, there is a spike in calcium deposition around Day 8, due to
osteoblasts depositing mineralized matrix. In conjuction to the calcium assay,
we reconstructed the constructs, Figure 5.5, that were imaged using µCT.
A similar spike in mineralized tissue can be seen around Day 11. Finally,
Figure 5.6 is of a reconstructed scaffold and shows the location of mineralized
tissue/ECM (red), soft tissue/ECM (yellow), and cells (green).
5.3.3 Shear Stress Distributions over Time
Additionally, we compared the localized fluid shear stress distributions for
the reconstructions at each intermittent time point. Figure 5.7 shows the
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Figure 5.4: Calcium levels present within each construct over the culture pe-
riod. The horizontal dotted line represents the background signal for an empty
construct. Values are given as the mean ± standard error of the mean (n =
4). The # signifies the significantly lowest value.
Figure 5.5: Summary of mineralized tissue (hard ECM) deposited in cultured
constructs reconstructed following µCT of Days 8, 11, and 16, respectively.
Calcium is indicated in red.
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Figure 5.6: Summary of mineralized tissue (hard ECM) deposited in Day 16
cultured constructs reconstructed following µCT. Mineralized tissue = Red,
PLLA fibers = Gray, Cells outside of ECM = Green, Soft tissue = Yellow
frequency of flow induced stresses. The data presented show a pronounced
increase shear stress levels with an increase in culture time.
Figure 5.7: Wall shear stress distributions based on the day a construct was
removed from culture and imaged.
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5.3.4 Effects of Calcium Deposition on Localized Shear
Fields
Figure 5.8 shows iso sections of reconstructed scaffolds, with wall shear stress
heat maps overlaid on top. It is evident that there are higher levels of shear
stress present during the later time points, which is supported distributions
shown in Figure 5.7.
5.3.5 Average Wall Shear Stress
Figure 5.9 displays the average wall shear stress calculated from simulations
following construct culture, resection, imaging, and reconstruction. Indeed,
the results do indeed show a continuous increase in shear as a culture time
increases, which is consistent with the previous sections.
5.4 Discussion
Following destructive analysis of the constructs, we evaluated the average wall
shear stress per construct as a function of culture time. As seen in Figure 5.9,
the average shear stress remains statisctically the same throughout the first 4
days of culture; however, after Day 8, there is a continual increase in the value
to the end of the culture period. This finding confirms our hypothesis about
bone tissue engineered cultures; that the shear stress experienced by the cells
will increase during culture. We attribute this to calcium deposition resulting
in a clogging of the construct pores. By holding the flow rate constant and
simaltaneusly decreasing the pore sizes, we effectively are increasing the fluid
velocity within the construct interior, and, along with it, the wall shear stress.
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(a) Wall shear heat map for Day 1 (far left) to Day 11 (far right)
(b) Wall shear heat map for Day 1 (far left) to Day 11 (far right)
(c) Scale bar: Values given in Pa
Figure 5.8: Summary of wall shear stress heat maps for constructs cultured un-
der osteoinducive conditions. Simulations for (a) were conducted using FLU-
ENT, and simulations for (b) were conducted using a custom LBM code.
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Figure 5.9: Summary of average shear stress per layer on the walls of the
scaffold for 0.1 mL/min flow rate. Values are given as the mean ± standard
error of the mean (n = 4). Significance calculated via ANOVA with Tukey
HSD Post-hoc analysis.
After evaluating the construct reconstructions, we can see a clear coorela-
tion to the amount of mineralized tissue and an overall increase in the magni-
tude of wall shear experienced within the pores of the construct. Indeed this
relationship is obvious in both Figure 5.7, showing the frequency distributions,
and Figure 5.8, which shows the wall shear heat maps. For the former, the
distributions show an increased frequency of elevated shear stress as culture
time increases, supporting the aforementioned increase in average wall shear
stress.
This finding is consistent when evaluating the heat maps. As culture time
increases, there is a higher density of elevated shear seen within the constructs.
This increase is most pronounced after day 11, which, according to the recon-
structions, is when large amounts of mineralized tissue is seen. An additional
positive finding is that the results are consistent when comparing the results
obtained utilizing FLUENT simulations and those from the in-house Lattice
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Boltzmann code, validating those methods.
Additionally, we evaluated the scaffold cellularity and the levels of mineral-
ized tissue deposited. As seen in Figure 5.3, we achieved a seeding efficiency of
40%, higher than most perfusion based seeding methods, and can be directly
attributed to the oscillatory seeding protocol we established in previous stud-
ies. Following the initial loss of cells during the seeding process, the amount
of cells per construct levels off after Day 4, consistent with previous results,
where an increase is not commonly seen as mature osteoblasts have both a
slower growth rate and become hidden by deposited calcium. We believe the
decrease in cellularity seen between Day 1 and Day 4 is due to increasing the
flow rate to a more osteoinducive level following the seeding protocol, and
thusly causing more cells to detach from the scaffold.
In Figures 5.4, 5.5, and 5.6, quantitative and qualitative measures of tissue
mineralization per construct are compared. In the former, a spike in calcium
production is seen between Day 4 and Day 8. This is consistent with our
previous studies. In comparison, Figure 5.5 shows an increase in mineralized
tissue found utilizing µCT between Day 8 and Day 11. We believe this lag time
is due to the cells beginning to deposit calcium that is not dense enough to be
picked up during imaging segmentation around Day 8. Along with this, Figure
5.6 shows a Day 16 reconstruction with mineralized tissue, soft tissue, and
cells. This image illustrates the state of the consstruct at the end of culture,
and gives insight into the density of mineralization that would occur if culture
continued. It is to be expected that the soft tissue visualized in the image will
eventually transition into fully mineralized tissue. Also of importance, the
cells (green) are not indicative of the total construct cellularity. Osteoblasts
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are commonly trapped inside deposited hydroxapatite in the body, and are
henceforth known as osteocytes. in vitro, it is difficult to quantify these cells
without destructively breaking down the mineral deposits to expose the cells.
5.5 Conclusion
In the presented manuscript, we hypothesized that the distribution of fluid
shear present at the walls of a construct cultered under osteoinducive condi-
tions will exhibit higher magnitudes as culture increases. In order to accom-
plish this, rat mesenchymal stem cells were dynamically seeded on 85% porous
spunbonded poly(l-lactic acid), and cultured with osteogenic media for up to
16 days under an osteoinducive flow rate. Following culture, these constructs
were either destructively evaluated with assays for cell viability and calcium
deposition, or imaged using µCT and reconstructed to allow for CFD simula-
tions to be performed. Average shear stress values and shear stress frequency
distributions obtained from simulations were compared with the assays, and
confirmed our original hypothesis. In terms of the calcium quantification assay,
a spike is seen around Day 8. This finding is supported by the reconstructions,
where imaging identified an increase in mineralized tissue around Day 11. Ad-
ditionally, the shear distribution heat maps show elevated magnitudes of shear
stress after Day 11. Finally, we proved that both the shear stress distributions
and the average shear stress per construct consistently increase as a function
of culture time. This is due to mineralization occuring within the pores of the
scaffold, decreasing pore diameter, and affectively increasing velocity withing
the pores. In future studies, a correlation or algorithm will be identified that
will give users the ability to predict the fluid shear distribution in a bone tissue
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engineered culture by only running fluid dynamic simulations on the empty
scaffolds.
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Chapter 6
Future Directions
The research projects presented herein answer vital problems plaguing the
bone tissue and tumor engineering fields. In particular, the studies answered
three main questions: 1) How can we improve both mesenchymal stem cell and
cancer cell adherence to the scaffolds? 2) In terms of flow-induced stresses,
what is the viability of 3D printing for manufacturing repeatable scaffold ar-
chitectures? 3) Do the shear stresses within a bone tissue engineered construct
change over the culture period? In summary, we accomplished the following:
1) developed a functionally flexible surface modification technique and increase
MSC seeding efficiency by 50%; 2) applied that modification scheme to increase
cancer cell adhesion by 25%; 3) brought to light the differences in shear stress
distributions between CAD models and the actual printed scaffolds; 4) both
validated the repeatability of 3D printing and provided a probibility density
function that describes the shear stress distributions therein; and 5) proved
the existence of increasing shear stresses withing bone cultures over time due
to calcium deposition.
An expansion of Chapters 2 and 3 would be the development of best prac-
129
tices for growing both a wider range of cells and a wider range of base materials
[7, 3, 2, 4]. As mentioned previously, RGD-mediated attachment of MSCs was
used as a proof of concept, whereas the n-cadherin mediated attachment was
a possible application of said method. For the former, work is needed to lever-
age the modifciation scheme for moiteies that can direct cellular recruitment
and differentiation states, in an attempt to circumvent the aforementioned
restrictions imposed by the FDA [10, 14, 6, 15, 5]. In regards to the latter,
the next step for the development of an in vitro tumor model is to monitor
the effectiveness of chemotherapeutic treatment on the modified constructs in
comparison to in vivo tumors [12]. Following the development and seeding
of the n-cadherin modified scaffold with tumor cells, chemotherapeutic agents
will be perfused in order to compare expressed genes, tissue organization, and
cell death. The overall goal of this study would be to compare the cellular
response to antitumor drugs in the tumor engineered environment to that of
a mouse model. A positive result would be to see no statistical difference in
the aforementioned tests, proving that the modification scheme presented in
this manuscript would allow for the development of clinically relevant samples
for in vitro diagnostic testing. Additionally, the development of a coculture
containing both bone and cancer cells of a metastatic lineage would lead to
models that can help researchers more effectively develop prospective drug
therapies [9].
There are three future goals for the advancement of the work presented in
Chapter 4: 1) expansion of the work to different materials; 2) fabrication of
the investigated scaffold orientations using different 3D printers; 3) prediction
of wall shear fields from only the CAD models. It has been well established
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that the polymers commonly used in tissue engineering, PLLA, PLGA, PPF,
etc., behave differently during FDM printing. Similarly, the various printers
on the market have different capabilities, such as resolution, that could affect
the resulting scaffold [13]. Furthermore, there are other factors that can skew
results (printer location, humidity, vibration, slicer software, build plate adhe-
sive, and post processing) that need to be investigated. Due to these reasons,
it is important to explore the validity of the study when taking into account
the aforementioned variabilities.
The third future goal, which is the development of a suite of predictive tools
that can anticipate the fluid flow field within constructs, is also applicable to
Chapter 5 as well. Predictive tools are not new to the field of tissue engineering,
and have helped researchers predict a wide range of responses from patient
responses to chemotherapeutics to material properties during culture [1, 8, 11].
As mentioned previously, the large discrepancy in wall shear magnitudes found
in the reconstructions and the CAD models is due to differenecs in surface
roughness and defects from the printing process. By utilizing machine learning
algorithms, these differences can be anticipated and would allow researchers to
tailor scaffold architectures for enhanced cell stimulation before running any
experiments, saving valuable time and resources.
The research projects presented in this manuscript aim to alleviate many of
the common problems facing the advancement of bone tissue and tumor engi-
neering. This is accomplished by developing a functionally flexible biomimetic
surface modification platform to increase cellular attachment for both mesenchymal-
derived cells and tumor cells, investigating the effects of 3D printing on the
resulting scaffold and flow-induced shear distributions, and characterizing the
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changes in flow-induced shear distributions caused by osteoblastic calcium de-
position. Indeed, issues still remain that impead a clinical transition; however,
the work presented herein push the fields of bone tissue and tumor engineering
ever closer to that goal.
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Appendix
Cell Spreading Calculations
Cell spreading is a measurement of the actin area covered by a cell. As such, it
is an easily measurable value that can indicate the binding strength between a
cell and a surface. In Chapters 2 and 3, it was used to quantify a functionalized
scaffold’s increased capacity for cellular attachment as a function of the extent
of expressed RGD or n-cadherin. In order to find this value, the following steps
were used: (1) scaffolds were first functionalized to express RGD or n-cadherin,
(2) cells were seeded and allowed to adhere, (3) cell seeded scaffolds were fixed,
stained, and imaged, and (4) resulting fluorescent images were examined using
the calculations found below. Steps 1-3 are outlined in detail in Chapters 2
and 3.
For the sample calculation provided below, ImageJ was used for area quan-
tification. To obtain this value, fluorescent images of either the cell nuclei or
actin were opened in ImageJ. Following this, the image was thresholded to
subtract any background and highlight the nuclei or actin, and the ”analyze
particles” tool was used to measure the pixel area of the highlighted image
features, which was converted to µm using the microscopes calibration data.
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The measurements of nuclei area to actin area were then normalized by diving
the latter by the former, giving the ratio of cell actin area to cell nuclei area.
This is necessary, because the actin per cell is not perfectly isolated from the
actin of its neighbor when there is a high density of cells, resulting in overlap.
An example calculation for values used in Figure 2.7 may be found below:
Total actin area from ImageJ = 36, 690µ2 (A.1)
Total nuclei area from ImageJ = 8, 636.8µ2 (A.2)
Cell spreading =
actin surface area
nucleus surface area
=
36, 690
8, 636.8
= 4.24 (A.3)
Fluent Methodology
In order to conduct the FLUENT simulations, we used the ANSYS Workbench
program, shown in Figure A1. Workbench contains a collection of various com-
putational programs useful for CFD or biomechanic studies. The FLUENT
(with meshing) program is one of the foremost CFD packages and is used
for both commercial and academic investigations. Three main steps were con-
ducted to generate the data presented in this manuscript: (1) scaffold meshing
for both CAD designs and reconstructions; (2) simulation domain setup; (3)
post-processing. A more detailed description for each stage is discussed below.
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Figure A.1: The ANSYS Workbench main screen. Available systems are shown
on the panels on the left. The area on the right may be used to organize a col-
lection of component modules, or connect modules for crosstalk. This screen-
shot shows the different FLUENT instances used to conduct CFD simulations
for scaffolds at a flow rate of 0.1 mL/min.
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Figure A.2: The FLUENT meshing prelaunch setup. Here you will select the
floating-point format and the processing type (serial, local parallel, distributed
parallel).
Meshing
To set the computational domain and mesh the scaffolds, start by opening
the Mesh option and setting the appropriate settings (Figure A2). Once the
module opens, import the CAD design or reconstructed scaffold file making
sure to select the correct unit system (Figure A3). Once complete, create the
bioreactor cassette, or computational domain, for the simulations (Figure A4).
It is important to alter the inlet side to create a larger flow inlet to allow for
proper flow field development, as discussed in Chapters 4 and 5. Following
this, convert both objects to mesh objects and set the sizing field and fluid
domain. The last step is to wrap the cassette and scaffold together, mesh the
system, and prepare the flow domain (Figures A5 and A6).
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Figure A.3: CAD file importation in FLUENT. FLUENT supports a wide
range of file formats, including .stl and .iges.
Figure A.4: Bounding box generation, which is equivalent to the cassette used
for perfusion bioreactors. As such, it is important to use the same dimensions
seen experimentally. The purpose of the box is to indicate the computational
domain for the simulations.
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Figure A.5: Auto meshing tool in FLUENT. It is recommended to use pyramid
meshing when possible to save computational time. The Set.. option may be
used to indicate mesh size and fluid domain fill type.
Figure A.6: Results from meshing in FLUENT. As shown in the screenshot,
important information, such as number of mesh nodes, is given in the command
prompt. Individual features may be highlighted in the left pane in order to
examine the success of the mesh.
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Figure A.7: The FLUENT computational Setup, Simulation, and Solution
main screen. The left pane contains each of the individual settings that can
be set. Available options for postprocessing are shown under the Results tab.
Simulation Setup and Post-Processing
Once meshing is complete, select the Setup module for the main page. Here,
we will select the flow regime, fluid and scaffold characteristics, boundary con-
ditions, simulation method, and computation settings (Figure A7). Settings
and rationale for each of these may be found in Chapters 4 and 5. Once
setup is complete, select to view normalized, unscaled residuals, set the hybrid
initialization with preliminary values, and run the simulation.
Once convergence has been achieved, results may be either: (1) visualized
using the Graphics tab in the Results section; or (2) exported for use in another
program. In either case, make sure to select the desired variable AND the
desired domain (bulk fluid, scaffold walls, or cassette walls).
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